Table of Contents Author Guidelines Submit a Manuscript
Erratum

An erratum for this article has been published. To view the erratum, please click here.

The Scientific World Journal
Volume 2012, Article ID 949535, 55 pages
http://dx.doi.org/10.1100/2012/949535
Review Article

Beyond the Definitions of the Phenotypic Complications of Sickle Cell Disease: An Update on Management

1Cardeza Foundation and Department of Medicine, Thomas Jefferson University, 1015 Walnut Street, Philadelphia, PA 19107, USA
2Wilmer Ophthalmological Institute, Johns Hopkins Hospital, 400 North Broadway, Baltimore, MD 21267, USA
3Department of Pediatrics, Aflac Cancer Center and Blood Disorders Service, Children’s Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA 30322, USA
4Department of Hematology, St. Jude Children’s Research Hospital, Memphis, TN 38105, USA
5Children’s Hospital & Research Center at Oakland, 744 52nd Street, Oakland, CA 94609, USA
6Division of Hematology, Children’s National Medical Center, 111 Michigan Avenue, N.W., Washington, DC 20010, USA
7Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 45229, USA

Received 13 February 2012; Accepted 1 April 2012

Academic Editors: O. O. Akinyanju, M. F. Sonati, and F. Traina

Copyright © 2012 Samir K. Ballas et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Perumbeti and P. Malik, “Genetic correction of sickle cell anemia and β-thalassemia: progress and new perspective,” The Scientific World Journal, vol. 10, pp. 644–654, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. M. H. Steinberg, “Sickle cell anemia, the first molecular disease: overview of molecular etiology, pathophysiology, and therapeutic approaches,” The Scientific World Journal, vol. 8, pp. 1295–1324, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. M. H. Steinberg, “Genetic etiologies for phenotypic diversity in sickle cell anemia,” The Scientific World Journal, vol. 9, pp. 46–67, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. S. K. Ballas, S. Lieff, L. J. Benjamin et al., “Definitions of the phenotypic manifestations of sickle cell disease,” American Journal of Hematology, vol. 85, no. 1, pp. 6–13, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Newaskar, K. A. Hardy, and C. R. Morris, “Asthma in sickle cell disease,” The Scientific World Journal, vol. 11, pp. 1138–1152, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. E. P. Vichinsky, L. D. Neumayr, J. I. Gold et al., “Neuropsychological dysfunction and neuroimaging abnormalities in neurologically intact adults with sickle cell anemia,” JAMA: Journal of the American Medical Association, vol. 303, no. 18, pp. 1823–1831, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Bentz and S. K. Ballas, “Neurobehavioral features of sickle cell disease,” Neuropsychiatry, Neuropsychology and Behavioral Neurology, vol. 7, no. 1, pp. 36–40, 1994. View at Google Scholar · View at Scopus
  8. T. R. Kinney, L. A. Sleeper, W. C. Wang et al., “Silent cerebral infarcts in sickle cell anemia: a risk factor analysis,” Pediatrics, vol. 103, no. 3, pp. 640–645, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. S. T. Miller, E. A. Macklin, C. H. Pegelow et al., “Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: a report from the Cooperative Study of Sickle Cell Disease,” Journal of Pediatrics, vol. 139, no. 3, pp. 385–390, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Gyang, K. Yeom, C. Hoppe, S. Partap, and M. Jeng, “Effect of chronic red cell transfusion therapy on vasculopathies and silent infarcts in patients with sickle cell disease,” American Journal of Hematology, vol. 86, no. 1, pp. 104–106, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. M. M. Dowling, C. T. Quinn, Z. R. Rogers, and G. R. Buchanan, “Acute silent cerebral infarction in children with sickle cell anemia,” Pediatric Blood and Cancer, vol. 54, no. 3, pp. 461–464, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. A. R. Goldstein, M. J. Anderson, and G. R. Serjeant, “Parvovirus associated aplastic crisis in homozygous sickle cell disease,” Archives of Disease in Childhood, vol. 62, no. 6, pp. 585–588, 1987. View at Publisher · View at Google Scholar
  13. H. A. Pearson, R. P. Spencer, and E. A. Cornelius, “Functional asplenia in sickle-cell anemia,” The New England Journal of Medicine, vol. 281, no. 17, pp. 923–926, 1969. View at Google Scholar · View at Scopus
  14. H. A. Pearson, D. Gallagher, and R. Chilcote, “Developmental pattern of splenic dysfunction in sickle cell disorders,” Pediatrics, vol. 76, no. 3, pp. 392–397, 1985. View at Google Scholar · View at Scopus
  15. A. I. Airede, “Acute splenic sequestration in a five-week-old infant with sickle cell disease,” Journal of Pediatrics, vol. 120, no. 1, p. 160, 1992. View at Google Scholar · View at Scopus
  16. D. L. Solanki, G. G. Kletter, and O. Castro, “Acute splenic sequestration crises in adults with sickle cell disease,” American Journal of Medicine, vol. 80, no. 5, pp. 985–990, 1986. View at Google Scholar · View at Scopus
  17. S. L. Leikin, D. Gallagher, T. R. Kinney, D. Sloane, P. Klug, and W. Rida, “Mortality in children and adolescents with sickle cell disease,” Pediatrics, vol. 84, no. 3, pp. 500–508, 1989. View at Google Scholar · View at Scopus
  18. E. P. Orringer, V. G. Fowler, C. M. Owens et al., “Case report: splenic infarction and acute splenic sequestration in adults with hemoglobin SC disease,” American Journal of the Medical Sciences, vol. 302, no. 6, pp. 374–379, 1991. View at Publisher · View at Google Scholar · View at Scopus
  19. A. M. Emond, R. Collis, and D. Darvill, “Acute splenic sequestration in homozygous sickle cell disease: natural history and management,” Journal of Pediatrics, vol. 107, no. 2, pp. 201–206, 1985. View at Google Scholar · View at Scopus
  20. F. M. Gill, L. A. Sleeper, S. J. Weiner et al., “Clinical events in the first decade in a cohort of infants with sickle cell disease,” Blood, vol. 86, no. 2, pp. 776–783, 1995. View at Google Scholar · View at Scopus
  21. C. S. R. Hatton, C. Bunch, and D. J. Weatherall, “Hepatic sequestration in sickle cell anaemia,” British Medical Journal, vol. 290, no. 6470, pp. 744–745, 1985. View at Google Scholar · View at Scopus
  22. J. M. Topley, D. W. Rogers, M. C. G. Stevens, and G. R. Serjeant, “Acute splenic sequestration and hypersplenism in the first five years in homozygous sickle cell disease,” Archives of Disease in Childhood, vol. 56, no. 10, pp. 765–769, 1981. View at Google Scholar · View at Scopus
  23. R. W. Powell, G. L. Levine, Y. M. Yang, and V. N. Mankad, “Acute splenic sequestration crisis in sickle cell disease: early detection and treatment,” Journal of Pediatric Surgery, vol. 27, no. 2, pp. 215–219, 1992. View at Publisher · View at Google Scholar · View at Scopus
  24. R. A. Seeler and M. Z. Shwiaki, “Acute splenic sequestration crises (ASSC) in young children with sickle cell anemia. Clinical observations in 20 episodes in 14 children,” Clinical Pediatrics, vol. 11, no. 12, pp. 701–704, 1972. View at Google Scholar · View at Scopus
  25. O. Idowu and A. Hayes-Jordan, “Partial splenectomy in children under 4 years of age with hemoglobinopathy,” Journal of Pediatric Surgery, vol. 33, no. 8, pp. 1251–1253, 1998. View at Google Scholar · View at Scopus
  26. E. Svarch, P. Vilorio, I. Nordet et al., “Partial splenectomy in children with sickle cell disease and repeated episodes of splenic sequestration,” Hemoglobin, vol. 20, no. 4, pp. 393–400, 1996. View at Google Scholar · View at Scopus
  27. E. Svarch, I. Nordet, and A. Gonzalez, “Overwhelming septicaemia in a patient with sickle cell/°thalassaemia and partial splenectomy,” British Journal of Haematology, vol. 104, no. 4, p. 930, 1999. View at Google Scholar · View at Scopus
  28. R. Grover and D. L. Wethers, “Management of acute splenic sequestration crisis in sickle cell disease,” Journal of the Association for Academic Minority Physicians, vol. 1, no. 3, pp. 67–70, 1990. View at Google Scholar · View at Scopus
  29. S. Rao and S. Gooden, “Splenic sequestration in sickle cell disease: role of transfusion therapy,” American Journal of Pediatric Hematology/Oncology, vol. 7, no. 3, pp. 298–301, 1985. View at Google Scholar · View at Scopus
  30. T. R. Kinney, R. E. Ware, W. H. Schultz, and H. C. Filston, “Long-term management of splenic sequestration in children with sickle cell disease,” Journal of Pediatrics, vol. 117, no. 2, pp. 194–199, 1990. View at Publisher · View at Google Scholar · View at Scopus
  31. S. P. Rao, S. T. Miller, and B. J. Cohen, “Transient aplastic crisis in patients with sickle cell disease: B19 parvovirus studies during a 7-year period,” American Journal of Diseases of Children, vol. 146, no. 11, pp. 1328–1330, 1992. View at Google Scholar · View at Scopus
  32. A. M. Yates, J. S. Hankins, N. A. Mortier, B. Aygun, and R. E. Ware, “Simultaneous acute splenic sequestration and transient aplastic crisis in children with sickle cell disease,” Pediatric Blood and Cancer, vol. 53, no. 3, pp. 479–481, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Bakhshi, S. A. Sarnaik, C. Becker, W. W. Shurney, M. Nigro, and S. Savaşan, “Acute encephalopathy with parvovirus B19 infection in sickle cell disease,” Archives of Disease in Childhood, vol. 87, no. 6, pp. 541–542, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. E. P. Vichinsky, L. D. Neumayr, A. N. Earles et al., “Causes and outcomes of the acute chest syndrome in sickle cell disease,” The New England Journal of Medicine, vol. 342, no. 25, pp. 1855–1865, 2000. View at Publisher · View at Google Scholar · View at Scopus
  35. J. S. Kinney, L. J. Anderson, J. Farrar et al., “Risk of adverse outcomes of pregnancy after human parvovirus B19 infection,” Journal of Infectious Diseases, vol. 157, no. 4, pp. 663–667, 1988. View at Google Scholar · View at Scopus
  36. S. K. Ballas and M. J. Marcolina, “Hyperhemolysis during the evolution of uncomplicated acute painful episodes in patients with sickle cell anemia,” Transfusion, vol. 46, no. 1, pp. 105–110, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. L. D. Petz, L. Calhoun, I. A. Shulman, C. Johnson, and R. M. Herron, “The sickle cell hemolytic transfusion reaction syndrome,” Transfusion, vol. 37, no. 4, pp. 382–392, 1997. View at Google Scholar · View at Scopus
  38. M. de Montalembert, M. D. Dumont, C. Heilbronner et al., “Delayed hemolytic transfusion reaction in children with sickle cell disease,” Haematologica, vol. 96, no. 6, pp. 801–807, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. W. F. Rosse, D. Gallagher, T. R. Kinney et al., “Transfusion and alloimmunization in sickle cell disease,” Blood, vol. 76, no. 7, pp. 1431–1437, 1990. View at Google Scholar · View at Scopus
  40. S. O. Wanko and M. J. Telen, “Transfusion management in sickle cell disease,” Hematology/Oncology Clinics of North America, vol. 19, no. 5, pp. 803–826, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. N. Win, H. Doughty, P. Telfer, B. J. Wild, and T. C. Pearson, “Hyperhemolytic transfusion reaction in sickle cell disease,” Transfusion, vol. 41, no. 3, pp. 323–328, 2001. View at Publisher · View at Google Scholar · View at Scopus
  42. J. O. Cullis, N. Win, J. M. Dudley, and T. Kaye, “Post-transfusion hyperhaemolysis in a patient with sickle cell disease: use of steroids and intravenous immunoglobulin to prevent further red cell destruction,” Vox Sanguinis, vol. 69, no. 4, pp. 355–357, 1995. View at Google Scholar · View at Scopus
  43. D. Anderson, K. Ali, V. Blanchette et al., “Guidelines on the use of intravenous immune globulin for hematologic conditions,” Transfusion Medicine Reviews, vol. 21, no. 1, pp. S9–S56, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. F. Noizat-Pirenne, D. Bachir, P. Chadebech et al., “Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease,” Haematologica, vol. 92, no. 12, pp. e132–e135, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. R. D. Soloway, B. W. Trotman, W. C. Maddrey, and F. Nakayama, “Pigment gallstone composition in patients with hemolysis or infection/stasis,” Digestive Diseases and Sciences, vol. 31, no. 5, pp. 454–460, 1986. View at Google Scholar · View at Scopus
  46. F. Charlotte, D. Bachir, M. Nenert et al., “Vascular lesions of the liver in sickle cell disease: a clinicopathological study in 26 living patients,” Archives of Pathology and Laboratory Medicine, vol. 119, no. 1, pp. 46–52, 1995. View at Google Scholar · View at Scopus
  47. T. M. Walker, I. R. Hambleton, and G. R. Serjeant, “Gallstones in sickle cell disease: observations from the Jamaican cohort study,” Journal of Pediatrics, vol. 136, no. 1, pp. 80–85, 2000. View at Google Scholar · View at Scopus
  48. A. H. Al-Salem and S. Qaisruddin, “The significance of biliary sludge in children with sickle cell disease,” Pediatric Surgery International, vol. 13, no. 1, pp. 14–16, 1998. View at Publisher · View at Google Scholar · View at Scopus
  49. T. M. Walker and G. R. Serjeant, “Biliary sludge in sickle cell disease,” Journal of Pediatrics, vol. 129, no. 3, pp. 443–445, 1996. View at Publisher · View at Google Scholar · View at Scopus
  50. S. P. Lee, K. Maher, and J. F. Nicholls, “Origin and fate of biliary sludge,” Gastroenterology, vol. 94, no. 1, pp. 170–176, 1988. View at Google Scholar · View at Scopus
  51. P. Vicari, M. V. F. Gil, R. de Cássia Rosário Cavalheiro, and M. S. Figueiredo, “Multiple primary choledocholithiasis in sickle cell disease,” Internal Medicine, vol. 47, no. 24, pp. 2169–2170, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. G. Currò, A. Meo, D. Ippolito, A. Pusiol, and E. Cucinotta, “Asymptomatic cholelithiasis in children with sickle cell disease: early or delayed cholecystectomy?” Annals of Surgery, vol. 245, no. 1, pp. 126–129, 2007. View at Publisher · View at Google Scholar · View at Scopus
  53. L. R. Bond, S. R. Hatty, M. E. C. Horn, M. Dick, H. B. Meire, and A. J. Bellingham, “Gall stones in sickle cell disease in the United Kingdom,” British Medical Journal, vol. 295, no. 6592, pp. 234–236, 1987. View at Google Scholar · View at Scopus
  54. L. R. Mills, D. Mwakyusa, and P. F. Milner, “Histopathologic features of liver biopsy specimens in sickle cell disease,” Archives of Pathology and Laboratory Medicine, vol. 112, no. 3, pp. 290–294, 1988. View at Google Scholar · View at Scopus
  55. J. B. Porter and F. T. Shah, “Iron overload in thalassemia and related conditions: therapeutic goals and assessment of response to chelation therapies,” Hematology/Oncology Clinics of North America, vol. 24, no. 6, pp. 1109–1130, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. J. S. Hankins, M. P. Smeltzer, M. B. McCarville et al., “Patterns of liver iron accumulation in patients with sickle cell disease and thalassemia with iron overload,” European Journal of Haematology, vol. 85, no. 1, pp. 51–57, 2010. View at Publisher · View at Google Scholar · View at Scopus
  57. K. Brown, C. Subramony, W. May et al., “Hepatic iron overload in children with sickle cell anemia on chronic transfusion therapy,” Journal of Pediatric Hematology/Oncology, vol. 31, no. 5, pp. 309–312, 2009. View at Publisher · View at Google Scholar · View at Scopus
  58. V. Berdoukas, T. Bohane, V. Tobias et al., “Liver iron concentration and fibrosis in a cohort of transfusion-dependent patients on long-term desferrioxamine therapy,” Hematology Journal, vol. 5, no. 7, pp. 572–578, 2005. View at Publisher · View at Google Scholar · View at Scopus
  59. P. Harmatz, E. Butensky, K. Quirolo et al., “Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy,” Blood, vol. 96, no. 1, pp. 76–79, 2000. View at Google Scholar · View at Scopus
  60. G. J. Kato, S. Martyr, W. C. Blackwelder et al., “Levels of soluble endothelium-derived adhesion molecules in patients with sickle cell disease are associated with pulmonary hypertension, organ dysfunction, and mortality,” British Journal of Haematology, vol. 130, no. 6, pp. 943–953, 2005. View at Publisher · View at Google Scholar · View at Scopus
  61. A. K. Bayazit and Y. Kilinç, “Natural coagulation inhibitors (protein C, protein S, antithrombin) in patients with sickle cell anemia in a steady state,” Pediatrics International, vol. 43, no. 6, pp. 592–596, 2001. View at Publisher · View at Google Scholar · View at Scopus
  62. A. Ojuawo, M. A. Adedoyin, and D. Fagbule, “Hepatic function tests in children with sickle cell anaemia during vaso occlusive crisis,” Central African Journal of Medicine, vol. 40, no. 12, pp. 342–345, 1994. View at Google Scholar · View at Scopus
  63. J. G. Wright, R. Malia, P. Cooper, P. Thomas, F. E. Preston, and G. R. Serjeant, “Protein C and protein S in homozygous sickle cell disease: does hepatic dysfunction contribute to low levels?” British Journal of Haematology, vol. 98, no. 3, pp. 627–631, 1997. View at Google Scholar · View at Scopus
  64. T. Terada, Y. Kitamura, and Y. Nakanuma, “Normal and abnormal development of the human intrahepatic biliary system: a review,” Tohoku Journal of Experimental Medicine, vol. 181, no. 1, pp. 19–32, 1997. View at Google Scholar · View at Scopus
  65. D. R. Linklater, L. Pemberton, S. Taylor, and W. Zeger, “Painful dilemmas: an evidence-based look at challenging clinical scenarios,” Emergency Medicine Clinics of North America, vol. 23, no. 2, pp. 367–392, 2005. View at Publisher · View at Google Scholar · View at Scopus
  66. D. Magid, E. K. Fishman, S. Charache, and S. S. Siegelman, “Abdominal pain in sickle cell disease: the role of CT,” Radiology, vol. 163, no. 2, pp. 325–328, 1987. View at Google Scholar · View at Scopus
  67. G. Karayalcin, F. Rosner, and K. Y. Kim, “Sickle cell anemia. Clinical manifestations in 100 patients and review of the literature,” American Journal of the Medical Sciences, vol. 269, no. 1, pp. 51–68, 1975. View at Google Scholar · View at Scopus
  68. M. G. Papadaki, A. C. Kattamis, I. G. Papadaki et al., “Abdominal ultrasonographic findings in patients with sickle-cell anaemia and thalassaemia intermedia,” Pediatric Radiology, vol. 33, no. 8, pp. 515–521, 2003. View at Publisher · View at Google Scholar · View at Scopus
  69. T. W. Bauer, G. W. Moore, and G. M. Hutchins, “The liver in sickle cell disease. A clinicopathologic study of 70 patients,” American Journal of Medicine, vol. 69, no. 6, pp. 833–837, 1980. View at Google Scholar · View at Scopus
  70. C. S. Johnson, M. Omata, and M. J. Tong, “Liver involvement in sickle cell disease,” Medicine, vol. 64, no. 5, pp. 349–356, 1985. View at Google Scholar · View at Scopus
  71. M. S. West, D. Wethers, J. Smith et al., “Laboratory profile of sickle cell disease: a cross-sectional analysis,” Journal of Clinical Epidemiology, vol. 45, no. 8, pp. 893–909, 1992. View at Publisher · View at Google Scholar · View at Scopus
  72. D. S. Darbari, R. H. N. Van Schaik, E. V. Capparelli, S. Rana, R. McCarter, and J. Van Den Anker, “UGT2B7 promoter variant −840G > A contributes to the variability in hepatic clearance of morphine in patients with sickle cell disease,” American Journal of Hematology, vol. 83, no. 3, pp. 200–202, 2008. View at Publisher · View at Google Scholar · View at Scopus
  73. A. L. Teixeira, M. B. Viana, M. L. Valadares Roquete, and N. H. Toppa, “Sickle cell disease: a clinical and histopathologic study of the liver in living children,” Journal of Pediatric Hematology/Oncology, vol. 24, no. 2, pp. 125–129, 2002. View at Publisher · View at Google Scholar · View at Scopus
  74. S. Hiran, “Multiorgan dysfunction syndrome in sickle cell disease,” Journal of Association of Physicians of India, vol. 53, pp. 19–22, 2005. View at Google Scholar · View at Scopus
  75. K. L. Hassell, J. R. Eckman, and P. A. Lane, “Acute multiorgan failure syndrome: a potentially catastrophic complication of severe sickle cell pain episodes,” American Journal of Medicine, vol. 96, no. 2, pp. 155–162, 1994. View at Publisher · View at Google Scholar · View at Scopus
  76. S. G. Delis, Z. Touloumis, A. Bourli, J. Madariaga, and C. Dervenis, “`Can exchange transfusions treat postoperative intrahepatic colestasis in patients with sickle cell anemia?” Transplantation Proceedings, vol. 38, no. 5, pp. 1385–1386, 2006. View at Publisher · View at Google Scholar · View at Scopus
  77. D. B. Costa, R. A. Miksad, M. S. Buff, Y. Wang, and B. J. Dezube, “Case of fatal sickle cell intrahepatic cholestasis despite use of exchange transfusion in an African-American patient,” Journal of the National Medical Association, vol. 98, no. 7, pp. 1183–1187, 2006. View at Google Scholar · View at Scopus
  78. S. C. Davies and M. Brozovic, “The presentation, management and prophylaxis of sickle cell disease,” Blood Reviews, vol. 3, no. 1, pp. 29–44, 1989. View at Google Scholar · View at Scopus
  79. T. W. Sheehy, D. E. Law, and B. H. Wade, “Exchange transfusion for sickle cell intrahepatic cholestasis,” Archives of Internal Medicine, vol. 140, no. 10, pp. 1364–1366, 1980. View at Publisher · View at Google Scholar · View at Scopus
  80. G. F. Perini, F. P. S. Santos, J. B. H. Ferraz Neto, D. Pasqualin, and N. Hamerschlak, “Acute sickle hepatic crisis after liver transplantation in a patient with sickle β-thalassemia,” Transplantation, vol. 90, no. 4, pp. 463–464, 2010. View at Publisher · View at Google Scholar · View at Scopus
  81. F. Lacaille, F. Lesage, and M. de Montalembert, “Acute hepatic crisis in children with sickle cell disease,” Journal of Pediatric Gastroenterology and Nutrition, vol. 39, no. 2, pp. 200–202, 2004. View at Google Scholar · View at Scopus
  82. E. C. Ebert, M. Nagar, and K. D. Hagspiel, “Gastrointestinal and Hepatic Complications of Sickle Cell Disease,” Clinical Gastroenterology and Hepatology, vol. 8, no. 6, pp. 483–489, 2010. View at Publisher · View at Google Scholar · View at Scopus
  83. S. Ahmed, R. K. Shahid, and L. A. Russo, “Unusual causes of abdominal pain: sickle cell anemia,” Best Practice and Research, vol. 19, no. 2, pp. 297–310, 2005. View at Publisher · View at Google Scholar · View at Scopus
  84. M. Mancao, B. Estrada, F. Wilson, M. Figarola, and R. Wesenberg, “Methicillin-resistant Staphylococcus aureus hepatic abscess in a patient with sickle-cell disease,” International Journal of Laboratory Hematology, vol. 29, no. 6, pp. 474–477, 2007. View at Publisher · View at Google Scholar · View at Scopus
  85. M. B. Garcia-Arias, C. Rodriguez-Galindo, F. A. Hoffer, and W. C. Wang, “Pyogenic hepatic abscess after percutaneous liver biopsy in a patient with sickle cell disease,” Journal of Pediatric Hematology/Oncology, vol. 27, no. 2, pp. 103–105, 2005. View at Publisher · View at Google Scholar · View at Scopus
  86. M. Lama, “Hepatic abscess in sickle cell anaemia: a rare manifestation,” Archives of Disease in Childhood, vol. 69, no. 2, pp. 242–243, 1993. View at Google Scholar · View at Scopus
  87. E. Harrington and M. A. Bleicher, “Cryptogenic hepatic abscess in two uncompromised children,” Journal of Pediatric Surgery, vol. 15, no. 5, pp. 660–662, 1980. View at Google Scholar · View at Scopus
  88. S. T. Shulman and M. O. Beem, “An unique presentation of sickle cell disease: pyogenic hepatic abscess,” Pediatrics, vol. 47, no. 6, pp. 1019–1022, 1971. View at Google Scholar · View at Scopus
  89. N. Ahmed and V. Chizhevsky, “Acute hepatic sequestration associated with pneumococcal infection in a 5-year-old boy with sickle β°-thalassemia: a case report and review of the literature,” Journal of Pediatric Hematology/Oncology, vol. 29, no. 10, pp. 720–724, 2007. View at Publisher · View at Google Scholar · View at Scopus
  90. W. E. Norris, “Acute hepatic sequestration in sickle cell disease,” Journal of the National Medical Association, vol. 96, no. 9, pp. 1235–1239, 2004. View at Google Scholar · View at Scopus
  91. C. S. R. Hatton, C. Bunch, and D. J. Weatherall, “Hepatic sequestration in sickle cell anaemia,” British Medical Journal, vol. 290, no. 6470, pp. 744–745, 1985. View at Google Scholar · View at Scopus
  92. M. R. Jeng, M. D. Rieman, P. E. Naidu et al., “Resolution of chronic hepatic sequestration in a patient with homozygous sickle cell disease receiving hydroxyurea,” Journal of Pediatric Hematology/Oncology, vol. 25, no. 3, pp. 257–260, 2003. View at Publisher · View at Google Scholar · View at Scopus
  93. E. S. H. Lee and P. C. M. Chu, “Reverse sequestration in a case of sickle crisis,” Postgraduate Medical Journal, vol. 72, no. 850, pp. 487–488, 1996. View at Google Scholar · View at Scopus
  94. E. Chuang, E. Ruchelli, and A. E. Mulberg, “Autoimmune liver disease and sickle cell anemia in children: a report of three cases,” Journal of Pediatric Hematology/Oncology, vol. 19, no. 2, pp. 159–162, 1997. View at Publisher · View at Google Scholar · View at Scopus
  95. C. M. El Younis, A. D. Min, M. I. Fiel et al., “Autoimmune hepatitis in a patient with sickle cell disease,” American Journal of Gastroenterology, vol. 91, no. 5, pp. 1016–1018, 1996. View at Google Scholar · View at Scopus
  96. M. F. Hasan, F. Marsh, G. Posner et al., “Chronic hepatitis C in patients with sickle cell disease,” American Journal of Gastroenterology, vol. 91, no. 6, pp. 1204–1206, 1996. View at Google Scholar · View at Scopus
  97. D. Ancel, X. Amiot, D. Chaslin-Ferbus et al., “Treatment of chronic hepatitis C in sickle cell disease and thalassaemic patients with interferon and ribavirin,” European Journal of Gastroenterology and Hepatology, vol. 21, no. 7, pp. 726–729, 2009. View at Publisher · View at Google Scholar · View at Scopus
  98. S. J. Van den Hazel, H. J. Metselaar, H. W. Tilanus et al., “Successful liver transplantation in a patient with sickle-cell anaemia,” Transplant International, vol. 16, no. 6, pp. 434–436, 2003. View at Publisher · View at Google Scholar · View at Scopus
  99. S. C. O. Gilli, I. F. S. Boin, L. S. Leonardi, A. C. M. Luzo, F. F. Costa, and S. T. O. Saad, “Liver transplantation in a patient with Sβo-thalassemia,” Transplantation, vol. 74, no. 6, pp. 896–898, 2002. View at Google Scholar · View at Scopus
  100. S. Emre, K. Kitibayashi, M. E. Schwartz et al., “Liver transplantation in a patient with acute liver failure due to sickle cell intrahepatic cholestasis,” Transplantation, vol. 69, no. 4, pp. 675–676, 2000. View at Google Scholar · View at Scopus
  101. S. Emre, M. E. Schwartz, B. Shneider et al., “Living related liver transplantation for acute liver failure in children,” Liver Transplantation and Surgery, vol. 5, no. 3, pp. 161–165, 1999. View at Google Scholar · View at Scopus
  102. E. Vichinsky, E. Butensky, E. Fung et al., “Comparison of organ dysfunction in transfused patients with SCD or β thalassemia,” American Journal of Hematology, vol. 80, no. 1, pp. 70–74, 2005. View at Publisher · View at Google Scholar · View at Scopus
  103. N. R. Ghugre and J. C. Wood, “Relaxivity-iron calibration in hepatic iron overload: probing underlying biophysical mechanisms using a Monte Carlo model,” Magnetic Resonance in Medicine, vol. 65, no. 3, pp. 837–847, 2011. View at Publisher · View at Google Scholar · View at Scopus
  104. J. S. Hankins, M. B. McCarville, R. B. Loeffler et al., “R2* magnetic resonance imaging of the liver in patients with iron overload,” Blood, vol. 113, no. 20, pp. 4853–4855, 2009. View at Publisher · View at Google Scholar · View at Scopus
  105. C. C. Silliman, V. M. Peterson, D. L. Mellman, D. J. Dixon, K. M. Hambidge, and P. A. Lane, “Iron chelation by deferoxamine in sickle cell patients with severe transfusion-induced hemosiderosis: a randomized, double-blind study of the dose-response relationship,” Journal of Laboratory and Clinical Medicine, vol. 122, no. 1, pp. 48–54, 1993. View at Google Scholar · View at Scopus
  106. J. L. Stumpf and M. E. Bonk, “Deferasirox,” American Journal of Health-System Pharmacy, vol. 64, no. 6, pp. 606–616, 2007. View at Publisher · View at Google Scholar · View at Scopus
  107. A. Cohen and E. Schwartz, “Iron chelation therapy in sickle cell anemia,” American Journal of Hematology, vol. 7, no. 1, pp. 69–76, 1979. View at Google Scholar · View at Scopus
  108. M. J. Pippard, “Iron overload and iron chelation therapy in thalassaemia and sickle cell haemoglobinopathies,” Acta Haematologica, vol. 78, no. 2-3, pp. 206–211, 1987. View at Google Scholar · View at Scopus
  109. E. B. Fung, P. Harmatz, M. Milet et al., “Morbidity and mortality in chronically transfused subjects with Thalassemia and Sickle Cell Disease: a report from the multi-center study of iron overload,” American Journal of Hematology, vol. 82, no. 4, pp. 255–265, 2007. View at Publisher · View at Google Scholar · View at Scopus
  110. E. B. Fung, P. R. Harmatz, P. D. K. Lee et al., “Increased prevalence of iron-overload associated endocrinopathy in thalassaemia versus sickle-cell disease,” British Journal of Haematology, vol. 135, no. 4, pp. 574–582, 2006. View at Publisher · View at Google Scholar · View at Scopus
  111. E. B. Fung, P. R. Harmatz, M. Milet et al., “Fracture prevalence and relationship to endocrinopathy in iron overloaded patients with sickle cell disease and thalassemia,” Bone, vol. 43, no. 1, pp. 162–168, 2008. View at Publisher · View at Google Scholar · View at Scopus
  112. P. Ginès and R. W. Schrier, “Renal failure in cirrhosis,” The New England Journal of Medicine, vol. 361, no. 13, pp. 1279–1290, 2009. View at Publisher · View at Google Scholar · View at Scopus
  113. R. Rodríguez-Roisin and M. J. Krowka, “Hepatopulmonary syndrome—a liver-induced lung vascular disorder,” The New England Journal of Medicine, vol. 358, no. 22, pp. 2318–2387, 2008. View at Publisher · View at Google Scholar · View at Scopus
  114. R. E. Stauber and H. Olschewski, “Portopulmonary hypertension: short review,” European Journal of Gastroenterology and Hepatology, vol. 22, no. 4, pp. 385–390, 2010. View at Publisher · View at Google Scholar · View at Scopus
  115. S. H. Shao and E. P. Orringer, “Sickle cell intrahepatic cholestasis: approach to a difficult problem,” American Journal of Gastroenterology, vol. 90, no. 11, pp. 2048–2050, 1995. View at Google Scholar · View at Scopus
  116. I. Khurshid, L. Anderson, G. H. Downie, and G. S. Pape, “Sickle cell disease, extreme hyperbilirubinemia, and pericardial tamponade: case report and review of the literature,” Critical Care Medicine, vol. 30, no. 10, pp. 2363–2367, 2002. View at Google Scholar · View at Scopus
  117. K. Irizarry, H. C. Rossbach, J. R. A. Ignacio et al., “Sickle cell intrahepatic cholestasis with cholelithiasis,” Pediatric Hematology and Oncology, vol. 23, no. 2, pp. 95–102, 2006. View at Publisher · View at Google Scholar · View at Scopus
  118. D. M. Brunetta, A. C. Silva-Pinto, M. do Carmo Favarin de Macedo, S. C. Bassi, J. V. Piccolo Feliciano, and F.B. Ribeiro, “Intrahepatic cholestasis in sickle cell disease: a case report,” Anemia, vol. 2011, Article ID 975731, 3 pages, 2011. View at Publisher · View at Google Scholar
  119. H. Issa, A. Al-Haddad, and A. Al-Salem, “Sickle cell cholangiopathy: an endoscopic retrograde cholangiopancreatography evaluation,” World Journal of Gastroenterology, vol. 15, no. 42, pp. 5316–5320, 2009. View at Publisher · View at Google Scholar · View at Scopus
  120. N. Zakaria, A. Knisely, B. Portmann et al., “Acute sickle cell hepatopathy represents a potential contraindication for percutaneous liver biopsy,” Blood, vol. 101, no. 1, pp. 101–103, 2003. View at Publisher · View at Google Scholar · View at Scopus
  121. S. Hillaire, C. Gardin, A. Attar et al., “Cholangiopathy and intrahepatic stones in sickle cell disease: coincidence or ischemic cholangiopathy?” American Journal of Gastroenterology, vol. 95, no. 1, pp. 300–301, 2000. View at Publisher · View at Google Scholar · View at Scopus
  122. G. R. Buchanan and B. E. Glader, “Benign course of extreme hyperbilirubinemia in sickle cell anemia: analysis of six cases,” Journal of Pediatrics, vol. 91, no. 1, pp. 21–24, 1977. View at Google Scholar · View at Scopus
  123. O. Akinyanju and F. Ladapo, “Cholelithiasis and biliary tract disease in sickle-cell disease in Nigerians,” Postgraduate Medical Journal, vol. 55, no. 644, pp. 400–402, 1979. View at Google Scholar · View at Scopus
  124. J. L. Cameron, W. C. Maddrey, and G. D. Zuidema, “Biliary tract disease in sickle cell anemia: surgical considerations,” Annals of Surgery, vol. 174, no. 4, pp. 702–710, 1971. View at Google Scholar · View at Scopus
  125. D. A. Nzeh and M. A. Adedoyin, “Sonographic pattern of gallbladder disease in children with sickle cell anaemia,” Pediatric Radiology, vol. 19, no. 5, pp. 290–292, 1989. View at Google Scholar · View at Scopus
  126. M. Z. Haider, S. Ashebu, P. Aduh, and A. D. Adekile, “Influence of α-thalassemia on cholelithiasis in SS patients with elevated Hb F,” Acta Haematologica, vol. 100, no. 3, pp. 147–150, 1998. View at Publisher · View at Google Scholar · View at Scopus
  127. A. J. Lopez, P. O'Keefe, M. Morrissey, and J. Pickleman, “Ceftriaxone-induced cholelithiasis,” Annals of Internal Medicine, vol. 115, no. 9, pp. 712–714, 1991. View at Google Scholar · View at Scopus
  128. S. D. St. Peter, S. J. Keckler, A. Nair et al., “Laparoscopic cholecystectomy in the pediatric population,” Journal of Laparoendoscopic and Advanced Surgical Techniques, vol. 18, no. 1, pp. 127–130, 2008. View at Publisher · View at Google Scholar · View at Scopus
  129. A. J. Jawad, K. Kurban, A. El-Bakry, A. Al-Rabeeah, M. Seraj, and A. Ammar, “Laparoscopic cholecystectomy for cholelithiasis during infancy and childhood: cost analysis and review of current indications,” World Journal of Surgery, vol. 22, no. 1, pp. 69–74, 1998. View at Publisher · View at Google Scholar · View at Scopus
  130. W. A. D'Alonza Jr. and S. Heyman, “Biliary scintigraphy in children with sickle cell anemia and acute abdominal pain,” Pediatric Radiology, vol. 15, no. 6, pp. 395–398, 1985. View at Google Scholar · View at Scopus
  131. A. N. Serafini, G. Spoliansky, and G. N. Sfakianakis, “Diagnostic studies in patients with sickle cell anemia and acute abdominal pain,” Archives of Internal Medicine, vol. 147, no. 6, pp. 1061–1062, 1987. View at Google Scholar · View at Scopus
  132. M. A. Jelali, A. Luciani, H. Kobeiter et al., “MRI features of intrahepatic extramedullary haematopoiesis in sickle cell anaemia,” Cancer Imaging, vol. 6, pp. 182–185, 2006. View at Publisher · View at Google Scholar · View at Scopus
  133. S. L. Werlin and J. P. Scott, “Is biliary sludge a stone-in-waiting?” Journal of Pediatrics, vol. 129, no. 3, pp. 321–322, 1996. View at Publisher · View at Google Scholar · View at Scopus
  134. S. Ahmed, A. K. Siddiqui, R. K. Siddiqui, M. Kimpo, L. Russo, and J. Mattana, “Acute pancreatitis during sickle cell vaso-occlusive painful crisis,” American Journal of Hematology, vol. 73, no. 3, pp. 190–193, 2003. View at Publisher · View at Google Scholar · View at Scopus
  135. H. Issa and A. H. Al-Salem, “Role of ERCP in the era of laparoscopic cholecystectomy for the evaluation of choledocholithiasis in sickle cell anemia,” World Journal of Gastroenterology, vol. 17, no. 14, pp. 1844–1847, 2011. View at Publisher · View at Google Scholar · View at Scopus
  136. K. A. Kudsk, R. F. Tranbaugh, and G. F. Sheldon, “Acute surgical illness in patients with sickle cell anemia,” American Journal of Surgery, vol. 142, no. 1, pp. 113–117, 1981. View at Google Scholar · View at Scopus
  137. F. M. Gill, L. A. Sleeper, S. J. Weiner et al., “Clinical events in the first decade in a cohort of infants with sickle cell disease,” Blood, vol. 86, no. 2, pp. 776–783, 1995. View at Google Scholar · View at Scopus
  138. M. C. G. Stevens, M. Padwick, and G. R. Serjeant, “Observations on the natural history of dactylitis in homozygous sickle cell disease,” Clinical Pediatrics, vol. 20, no. 5, pp. 311–317, 1981. View at Google Scholar · View at Scopus
  139. D. R. Powars, L. S. Chan, A. Hiti, E. Ramicone, and C. Johnson, “Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients,” Medicine, vol. 84, no. 6, pp. 363–376, 2005. View at Publisher · View at Google Scholar · View at Scopus
  140. S. T. Miller, L. A. Sleeper, C. H. Pegelow et al., “Prediction of adverse outcomes in children with sickle cell disease,” The New England Journal of Medicine, vol. 342, no. 2, pp. 83–89, 2000. View at Publisher · View at Google Scholar · View at Scopus
  141. L. Foucan, D. Ekouevi, M. Etienne-Julan, L. R. Salmi, and J. P. Diara, “Early onset dactylitis associated with the occurrence of severe events in children with sickle cell anaemia. The Paediatric Cohort of Guadeloupe (1984–1999),” Paediatric and Perinatal Epidemiology, vol. 20, no. 1, pp. 59–66, 2006. View at Publisher · View at Google Scholar · View at Scopus
  142. D. R. Powars, “Natural history of sickle cell disease. The first ten years,” Seminars in Hematology, vol. 12, no. 3, pp. 267–285, 1975. View at Google Scholar · View at Scopus
  143. C. T. Quinn, N. J. Lee, E. P. Shull, N. Ahmad, Z. R. Rogers, and G. R. Buchanan, “Prediction of adverse outcomes in children with sickle cell anemia: a study of the Dallas Newborn Cohort,” Blood, vol. 111, no. 2, pp. 544–548, 2008. View at Publisher · View at Google Scholar · View at Scopus
  144. O. Oniyangi and A. A. Omari, “Malaria chemoprophylaxis in sickle cell disease,” Cochrane Database of Systematic Reviews (Online), no. 4, Article ID CD003489, 2006. View at Google Scholar · View at Scopus
  145. W. C. Wang, R. E. Ware, S. T. Miller et al., “Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG),” The Lancet, vol. 377, no. 9778, pp. 1663–1672, 2011. View at Publisher · View at Google Scholar · View at Scopus
  146. A. Almeida and I. Roberts, “Bone involvement in sickle cell disease,” British Journal of Haematology, vol. 129, no. 4, pp. 482–490, 2005. View at Publisher · View at Google Scholar · View at Scopus
  147. M. Sadat-Ali, A. Al-Elq, O. Sultan, and H. Al-Turki, “Secondary osteoporosis due to sickle cell anemia: do sex steroids play a role?” Indian Journal of Medical Sciences, vol. 62, no. 5, pp. 193–198, 2008. View at Google Scholar · View at Scopus
  148. M. Sarrai, H. Duroseau, J. D'Augustine, S. Moktan, and R. Bellevue, “Bone mass density in adults with sickle cell disease,” British Journal of Haematology, vol. 136, no. 4, pp. 666–672, 2007. View at Publisher · View at Google Scholar · View at Scopus
  149. R. G. Miller, J. B. Segal, B. H. Ashar et al., “High prevalence and correlates of low bone mineral density in young adults with sickle cell disease,” American Journal of Hematology, vol. 81, no. 4, pp. 236–241, 2006. View at Publisher · View at Google Scholar · View at Scopus
  150. A. M. Buison, D. A. Kawchak, J. I. Schall et al., “Bone area and bone mineral content deficits in children with sickle cell disease,” Pediatrics, vol. 116, no. 4, pp. 943–949, 2005. View at Publisher · View at Google Scholar · View at Scopus
  151. Y. Serarslan, A. Kalaci, C. Özkan, Y. Doǧramaci, C. Çokluk, and A. N. Yanat, “Morphometry of the thoracolumbar vertebrae in sickle cell disease,” Journal of Clinical Neuroscience, vol. 17, no. 2, pp. 182–186, 2010. View at Publisher · View at Google Scholar · View at Scopus
  152. G. Baldanzi, F. Traina, J. F. M. Neto, A. O. Santos, C. D. Ramos, and S. T. O. Saad, “Low bone mass density is associated with hemolysis in Brazilian patients with sickle cell disease,” Clinics, vol. 66, no. 5, pp. 801–805, 2011. View at Publisher · View at Google Scholar · View at Scopus
  153. H. Al-Turki, “Influence of pregnancy on bone mass in sickle cell anemia,” West African Journal of Medicine, vol. 28, no. 3, pp. 169–172, 2009. View at Google Scholar · View at Scopus
  154. A. H. Al-Elq, H. A. Al-Turki, O. A. Sultan, and M. Sadat-Ali, “Influence of androgens on bone mass in young women with sickle cell anemia,” Saudi Medical Journal, vol. 29, no. 7, pp. 980–983, 2008. View at Google Scholar · View at Scopus
  155. A. T. Soliman, H. Bererhi, A. Darwish, M. M. Alzalabani, Y. Wali, and B. Ansari, “Decreased bone mineral density in prepubertal children with sickle cell disease: correlation with growth parameters, degree of siderosis and secretion of growth factors,” Journal of Tropical Pediatrics, vol. 44, no. 4, pp. 194–198, 1998. View at Google Scholar · View at Scopus
  156. E. B. Fung, P. R. Harmatz, M. Milet et al., “Fracture prevalence and relationship to endocrinopathy in iron overloaded patients with sickle cell disease and thalassemia,” Bone, vol. 43, no. 1, pp. 162–168, 2008. View at Publisher · View at Google Scholar · View at Scopus
  157. E. Terpos and E. Voskaridou, “Treatment options for thalassemia patients with osteoporosis,” Annals of the New York Academy of Sciences, vol. 1202, pp. 237–243, 2010. View at Publisher · View at Google Scholar · View at Scopus
  158. E. Voskaridou and E. Terpos, “Pathogenesis and management of osteoporosis in thalassemia,” Pediatric Endocrinology Reviews, vol. 6, no. 1, supplement, pp. 86–93, 2008. View at Google Scholar · View at Scopus
  159. B. L. Riggs, S. Khosla, and L. J. Melton, “A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men,” Journal of Bone and Mineral Research, vol. 13, no. 5, pp. 763–773, 1998. View at Publisher · View at Google Scholar · View at Scopus
  160. A. T. Soliman, N. El Banna, I. AlSalmi, V. De Silva, A. Craig, and M. Asfour, “Growth hormone secretion and circulating insulin-like growth factor-I (IGF-I) and IGF binding protein-3 concentrations in children with sickle cell disease,” Metabolism, vol. 46, no. 11, pp. 1241–1245, 1997. View at Publisher · View at Google Scholar · View at Scopus
  161. G. Nunlee-Bland, S. R. Rana, P. E. Houston-Yu, and W. Odonkor, “Growth hormone deficiency in patients with sickle cell disease and growth failure,” Journal of Pediatric Endocrinology and Metabolism, vol. 17, no. 4, pp. 601–606, 2004. View at Google Scholar · View at Scopus
  162. I. Osunkwo, E. I. Hodgman, K. Cherry et al., “Vitamin D deficiency and chronic pain in sickle cell disease,” British Journal of Haematology, vol. 153, no. 4, pp. 538–540, 2011. View at Publisher · View at Google Scholar · View at Scopus
  163. E. Nur, W. Mairuhu, B. J. Biemond et al., “Urinary markers of bone resorption, pyridinoline and deoxypyridinoline, are increased in sickle cell patients with further increments during painful crisis,” American Journal of Hematology, vol. 85, no. 11, pp. 902–904, 2010. View at Publisher · View at Google Scholar · View at Scopus
  164. M. A. F. El-Hazmi, H. M. Bahakim, and I. Al-Fawaz, “Endocrine functions in sickle cell anaemia patients,” Journal of Tropical Pediatrics, vol. 38, no. 6, pp. 307–313, 1992. View at Google Scholar · View at Scopus
  165. B. S. Zemel, D. A. Kawchak, K. Ohene-Frempong, J. I. Schall, and V. A. Stallings, “Effects of delayed pubertal development, nutritional status, and disease severity on longitudinal patterns of growth failure in children with sickle cell disease,” Pediatric Research, vol. 61, no. 5, pp. 607–613, 2007. View at Publisher · View at Google Scholar · View at Scopus
  166. E. B. Fung, D. A. Kawchak, B. S. Zemel, A. J. Rovner, K. Ohene-Frempong, and V. A. Stallings, “Markers of bone turnover are associated with growth and development in young subjects with sickle cell anemia,” Pediatric Blood and Cancer, vol. 50, no. 3, pp. 620–623, 2008. View at Publisher · View at Google Scholar · View at Scopus
  167. K. Yamasaki and H. Hagiwara, “Excess iron inhibits osteoblast metabolism,” Toxicology Letters, vol. 191, no. 2-3, pp. 211–215, 2009. View at Publisher · View at Google Scholar · View at Scopus
  168. J. Tsay, Z. Yang, F. P. Ross et al., “Bone loss caused by iron overload in a murine model: importance of oxidative stress,” Blood, vol. 116, no. 14, pp. 2582–2589, 2010. View at Publisher · View at Google Scholar · View at Scopus
  169. P. Guggenbuhl, P. Fergelot, M. Doyard et al., “Bone status in a mouse model of genetic hemochromatosis,” Osteoporosis International, vol. 22, no. 8, pp. 2313–2319, 2011. View at Publisher · View at Google Scholar · View at Scopus
  170. A. T. Soliman, M. ElZalabany, M. Amer, and B. M. Ansari, “Growth and pubertal development in transfusion-dependent children and adolescents with thalassaemia major and sickle cell disease: a comparative study,” Journal of Tropical Pediatrics, vol. 45, no. 1, pp. 23–30, 1999. View at Google Scholar · View at Scopus
  171. R. D. Pollak, E. Rachmilewitz, A. Blumenfeld, M. Idelson, and A. W. Goldfarb, “Bone mineral metabolism in adults with β-thalassaemia major and intermedia,” British Journal of Haematology, vol. 111, no. 3, pp. 902–907, 2000. View at Publisher · View at Google Scholar · View at Scopus
  172. S. Valimaki, R. Tahtela, K. Kainulainen et al., “Relation of collagen type I alpha 1 (COLIA 1) and vitamin D receptor genotypes to bone mass, turnover, and fractures in early postmenopausal women and to hip fractures in elderly people,” European Journal of Internal Medicine, vol. 12, no. 1, pp. 48–56, 2001. View at Publisher · View at Google Scholar · View at Scopus
  173. B. Wonke, C. Jensen, J. J. Hanslip et al., “Genetic and acquired predisposing factors and treatment of osteoporosis in thalassaemia major,” Journal of Pediatric Endocrinology and Metabolism, vol. 11, no. 3, supplement, pp. 795–801, 1998. View at Google Scholar · View at Scopus
  174. M. Ferrara, S. M. R. Matarese, M. Francese et al., “Effect of VDR polymorphisms on growth and bone mineral density in homozygous beta thalassaemia,” British Journal of Haematology, vol. 117, no. 2, pp. 436–440, 2002. View at Publisher · View at Google Scholar · View at Scopus
  175. G. M. Blake and I. Fogelman, “The role of DXA bone density scans in the diagnosis and treatment of osteoporosis,” Postgraduate Medical Journal, vol. 83, no. 982, pp. 509–517, 2007. View at Publisher · View at Google Scholar · View at Scopus
  176. G. Baldanzi, S. Pietronave, D. Locarno et al., “Diacylglycerol kinases are essential for hepatocyte growth factor-dependent proliferation and motility of Kaposi's sarcoma cells,” Cancer Science, vol. 102, no. 7, pp. 1329–1336, 2011. View at Publisher · View at Google Scholar · View at Scopus
  177. J. Bahebeck, M. Ngowe Ngowe, M. Monny Lobe, M. Sosso, and P. Hoffmeyer, “Stress fracture of the femur: a rare complication of sickle cell disease,” Revue de Chirurgie Orthopedique et Reparatrice de l'Appareil Moteur, vol. 88, no. 8, pp. 816–818, 2002. View at Google Scholar · View at Scopus
  178. F. Jaiyesimi, R. Pandey, D. Bux, Y. Sreekrishna, F. Zaki, and N. Krishnamoorthy, “Sickle cell morbidity profile in Omani children,” Annals of Tropical Paediatrics, vol. 22, no. 1, pp. 45–52, 2002. View at Publisher · View at Google Scholar · View at Scopus
  179. W. W. Ebong, “Pathological fracture complicating long bone osteomyelitis in patients with sickle cell disease,” Journal of Pediatric Orthopaedics, vol. 6, no. 2, pp. 177–181, 1986. View at Google Scholar · View at Scopus
  180. O. Johnell and J. A. Kanis, “An estimate of the worldwide prevalence and disability associated with osteoporotic fractures,” Osteoporosis International, vol. 17, no. 12, pp. 1726–1733, 2006. View at Publisher · View at Google Scholar · View at Scopus
  181. M. Sadat-Ali, A. H. Al-Elq, O. Sultan, H. Al-Turki, R. Bukhari, and F. Al-Mulhim, “Low bone mass due to sickle cell anemia: is it becoming a real issue?” West African Journal of Medicine, vol. 27, no. 4, pp. 218–223, 2008. View at Google Scholar · View at Scopus
  182. E. Voskaridou, E. Terpos, G. Spina et al., “Pamidronate is an effective treatment for osteoporosis in patients with beta-thalassaemia,” British Journal of Haematology, vol. 123, no. 4, pp. 730–737, 2003. View at Publisher · View at Google Scholar · View at Scopus
  183. L. Ward, A. C. Tricco, P. Phuong et al., “Bisphosphonate therapy for children and adolescents with secondary osteoporosis,” Cochrane Database of Systematic Reviews (Online), no. 4, Article ID CD005324, 2007. View at Google Scholar · View at Scopus
  184. I. R. Reid, “Bisphosphonate therapy for secondary osteoporosis: adult perspective,” Hormone Research in Paediatrics, vol. 76, no. 1, supplement, pp. 28–32, 2011. View at Publisher · View at Google Scholar · View at Scopus
  185. K. A. Kennel and M. T. Drake, “Adverse effects of bisphosphonates: implications for osteoporosis management,” Mayo Clinic Proceedings, vol. 84, no. 7, pp. 632–638, 2009. View at Publisher · View at Google Scholar · View at Scopus
  186. D. Smiley, S. Dagogo-Jack, and G. Umpierrez, “Therapy insight: metabolic and endocrine disorders in sickle cell disease,” Nature Clinical Practice Endocrinology and Metabolism, vol. 4, no. 2, pp. 102–109, 2008. View at Publisher · View at Google Scholar · View at Scopus
  187. S. F. Ahmed, P. Tucker, A. Mayo, A. M. Wallace, and I. A. Hughes, “Randomized, crossover comparison study of the short-term effect of oral testosterone undecanoate and intramuscular testosterone depot on linear growth and serum bone alkaline phosphatase,” Journal of Pediatric Endocrinology and Metabolism, vol. 17, no. 7, pp. 941–950, 2004. View at Google Scholar · View at Scopus
  188. S. H. O'Brien, J. Klima, S. Reed, D. Chisolm, E. B. Schwarz, and K. J. Kelleher, “Hormonal contraception use and pregnancy in adolescents with sickle cell disease: analysis of Michigan Medicaid claims,” Contraception, vol. 83, no. 2, pp. 134–137, 2011. View at Publisher · View at Google Scholar · View at Scopus
  189. N. Tageja, M. Racovan, J. Valent, and J. Zonder, “Myonecrosis in sickle cell anemia-overlooked and underdiagnosed,” Case Reports in Medicine, vol. 2010, Article ID 659031, 3 pages, 2010. View at Publisher · View at Google Scholar
  190. J. Valeriano-Marcet and L. D. Kerr, “Myonecrosis and myofibrosis as complications of sickle cell anemia,” Annals of Internal Medicine, vol. 115, no. 2, pp. 99–101, 1991. View at Google Scholar · View at Scopus
  191. S. Mani and T. P. Duffy, “Sickle myonecrosis revisited,” American Journal of Medicine, vol. 95, no. 5, pp. 525–530, 1993. View at Publisher · View at Google Scholar · View at Scopus
  192. B. B. Dorwart and T. G. Gabuzda, “Symmetric myositis and fasciitis: a complication of sickle cell anemia during vasoocclusion,” Journal of Rheumatology, vol. 12, no. 3, pp. 590–595, 1985. View at Google Scholar · View at Scopus
  193. S. W. Kim and S. S. Kim, “Myonecrosis of paralumbar spine muscle,” Spine, vol. 36, no. 17, pp. E1162–E1165, 2011. View at Publisher · View at Google Scholar · View at Scopus
  194. T. O. F. de Souza, D. A. Mesquita, R. A. M. Ferrari et al., “Phototherapy with low-level laser affects the remodeling of types I and III collagen in skeletal muscle repair,” Lasers in Medical Science, vol. 26, no. 6, pp. 803–814, 2011. View at Publisher · View at Google Scholar · View at Scopus
  195. D. K. Kaul, X. D. Liu, S. Choong, J. D. Belcher, G. M. Vercellotti, and R. P. Hebbel, “Anti-inflammatory therapy ameliorates leukocyte adhesion and microvascular flow abnormalities in transgenic sickle mice,” American Journal of Physiology, vol. 287, no. 1, pp. H293–H301, 2004. View at Publisher · View at Google Scholar · View at Scopus
  196. J. Chang, P. A. Shi, E. Y. Chiang, and P. S. Frenette, “Intravenous immunoglobulins reverse acute vaso-occlusive crises in sickle cell mice through rapid inhibition of neutrophil adhesion,” Blood, vol. 111, no. 2, pp. 915–923, 2008. View at Publisher · View at Google Scholar · View at Scopus
  197. K. I. Ataga, “Novel therapies in sickle cell disease,” Hematology, vol. 2009, no. 1, pp. 54–61, 2009. View at Google Scholar · View at Scopus
  198. P. F. Milner, A. P. Kraus, J. I. Sebes et al., “Sickle cell disease as a cause of osteonecrosis of the femoral head,” The New England Journal of Medicine, vol. 325, no. 21, pp. 1476–1481, 1991. View at Google Scholar · View at Scopus
  199. C. J. Lavernia and R. J. Sierra, “Core decompression in atraumatic osteonecrosis of the hip,” Journal of Arthroplasty, vol. 15, no. 2, pp. 171–178, 2000. View at Google Scholar · View at Scopus
  200. A. Ashley-Koch, C. C. Murphy, M. J. Khoury, and C. A. Boyle, “Contribution of sickle cell disease to the occurrence of developmental disabilities: a population-based study,” Genetics in Medicine, vol. 3, no. 3, pp. 181–186, 2001. View at Google Scholar · View at Scopus
  201. G. J. Hanker and H. C. Amstutz, “Osteonecrosis of the hip in the sickle-cell diseases. Treatment and complications,” Journal of Bone and Joint Surgery—Series A, vol. 70, no. 4, pp. 499–506, 1988. View at Google Scholar · View at Scopus
  202. P. Hernigou, F. Galacteros, D. Bachir, and D. Goutallier, “Deformities of the hip in adults who have sickle-cell disease and had avascular necrosis in childhood: a natural history of fifty-two patients,” Journal of Bone and Joint Surgery—Series A, vol. 73, no. 1, pp. 81–92, 1991. View at Google Scholar · View at Scopus
  203. S. K. Kim and J. H. Miller, “Natural history and distribution of bone and bone marrow infarction in sickle hemoglobinopathies,” Journal of Nuclear Medicine, vol. 43, no. 7, pp. 896–900, 2002. View at Google Scholar · View at Scopus
  204. P. Lafforgue, “Pathophysiology andnatural history ofavascular necrosis ofbone,” Joint Bone Spine, vol. 73, no. 5, pp. 500–507, 2006. View at Publisher · View at Google Scholar · View at Scopus
  205. A. D. Adekile, R. Gupta, F. Yacoub, T. Sinan, M. Al-Bloushi, and M. Z. Haider, “Avascular necrosis of the hip in children with sickle cell disease and high Hb F: magnetic resonance imaging findings and influence of α-thalassemia trait,” Acta Haematologica, vol. 105, no. 1, pp. 27–31, 2001. View at Publisher · View at Google Scholar · View at Scopus
  206. L. D. Neumayr, C. Aguilar, A. N. Earles et al., “Physical therapy alone compared with core decompression and physical therapy for femoral head osteonecrosis in sickle cell disease: results of a multicenter study at a mean of three years after treatment,” Journal of Bone and Joint Surgery—Series A, vol. 88, no. 12, pp. 2573–2582, 2006. View at Publisher · View at Google Scholar · View at Scopus
  207. P. Hernigou, A. Habibi, D. Bachir, and F. Galacteros, “The natural history of asymptomatic osteonecrosis of the femoral head in adults with sickle cell disease,” Journal of Bone and Joint Surgery—Series A, vol. 88, no. 12, pp. 2565–2572, 2006. View at Publisher · View at Google Scholar · View at Scopus
  208. J. I. Sebes and A. P. Kraus, “Avascular necrosis of the hip in the sickle cell hemoglobinopathies,” Canadian Association of Radiologists Journal, vol. 34, no. 2, pp. 136–139, 1983. View at Google Scholar · View at Scopus
  209. N. Meddeb, N. Gandoura, M. Gandoura, and S. Sellami, “Osteoarticular manifestations in sickle cell disease,” Tunisie Medicale, vol. 81, no. 7, pp. 441–447, 2003. View at Google Scholar · View at Scopus
  210. H. J. Mankin, “Nontraumatic necrosis of bone (osteonecrosis),” The New England Journal of Medicine, vol. 326, no. 22, pp. 1473–1479, 1992. View at Google Scholar · View at Scopus
  211. P. R. Koduri, B. Agbemadzo, and S. Nathan, “Hemoglobin S-C disease revisited: clinical study of 106 adults,” American Journal of Hematology, vol. 68, no. 4, pp. 298–300, 2001. View at Publisher · View at Google Scholar · View at Scopus
  212. R. Marouf, R. Gupta, M. Z. Haider, H. Al-Wazzan, and A. D. Adekile, “Avascular necrosis of the femoral head in adult Kuwaiti sickle cell disease patients,” Acta Haematologica, vol. 110, no. 1, pp. 11–15, 2003. View at Publisher · View at Google Scholar · View at Scopus
  213. H. E. Ware, A. P. Brooks, R. Toye, and S. I. Berney, “Sickle cell disease and silent avascular necrosis of the hip,” Journal of Bone and Joint Surgery—Series B, vol. 73, no. 6, pp. 947–949, 1991. View at Google Scholar · View at Scopus
  214. H. H. M. Knox-Macaulay, “Sickle cell disease in Sierra Leone: a clinical and haematological analysis in older children and adults,” Annals of Tropical Medicine and Parasitology, vol. 77, no. 4, pp. 411–419, 1983. View at Google Scholar · View at Scopus
  215. D. R. Powars, A. Hiti, E. Ramicone, C. Johnson, and L. Chan, “Outcome in hemoglobin SC disease: a four-decade observational study of clinical, hematologic, and genetic factors,” American Journal of Hematology, vol. 70, no. 3, pp. 206–215, 2002. View at Publisher · View at Google Scholar · View at Scopus
  216. D. G. Nathan, “Search for improved therapy of sickle cell anemia,” Journal of Pediatric Hematology/Oncology, vol. 24, no. 9, pp. 700–703, 2002. View at Publisher · View at Google Scholar · View at Scopus
  217. H. J. Clarke, R. H. Jinnah, A. F. Brooker, and J. D. Michaelson, “Total replacement of the hip for avascular necrosis in sickle cell disease,” Journal of Bone and Joint Surgery—Series B, vol. 71, no. 3, pp. 465–470, 1989. View at Google Scholar · View at Scopus
  218. A. L. Akinyoola, I. A. Adediran, C. M. Asaleye, and A. R. Bolarinwa, “Risk factors for osteonecrosis of the femoral head in patients with sickle cell disease,” International Orthopaedics, vol. 33, no. 4, pp. 923–926, 2009. View at Publisher · View at Google Scholar · View at Scopus
  219. H. E. Ware, A. P. Brooks, R. Toye, and S. I. Berney, “Sickle cell disease and silent avascular necrosis of the hip,” Journal of Bone and Joint Surgery—Series B, vol. 73, no. 6, pp. 947–949, 1991. View at Google Scholar · View at Scopus
  220. R. E. J. Lee, J. S. R. Golding, and G. R. Serjeant, “The radiological features of avascular necrosis of the femoral head in homozygous sicke cell disease,” Clinical Radiology, vol. 32, no. 2, pp. 205–214, 1981. View at Google Scholar · View at Scopus
  221. M. Athanassiou-Metaxa, J. Kirkos, A. Koussi, E. Hatzipantelis, I. Tsatra, and M. Economou, “Avascular necrosis of the femoral head among children and adolescents with sickle cell disease in Greece,” Haematologica, vol. 87, no. 7, pp. 771–772, 2002. View at Google Scholar · View at Scopus
  222. J. K. Bradway and B. F. Morrey, “The natural history of the silent hip in bilateral atraumatic osteonecrosis,” Journal of Arthroplasty, vol. 8, no. 4, pp. 383–387, 1993. View at Google Scholar · View at Scopus
  223. P. Hernigou, D. Bachir, and F. Galacteros, “The natural history of symptomatic osteonecrosis in adults with sickle-cell disease,” Journal of Bone and Joint Surgery—Series A, vol. 85, no. 3, pp. 500–504, 2003. View at Google Scholar · View at Scopus
  224. H. R. Johannson, M. G. Zywiel, D. R. Marker, L. C. Jones, M. S. McGrath, and M. A. Mont, “Osteonecrosis is not a predictor of poor outcomes in primary total hip arthroplasty: a systematic literature review,” International Orthopaedics, vol. 35, no. 4, pp. 465–473, 2011. View at Publisher · View at Google Scholar · View at Scopus
  225. M. A. Mont, M. G. Zywiel, D. R. Marker, M. S. McGrath, and R. E. Delanois, “The natural history of untreated asymptomatic osteonecrosis of the femoral head: a systematic literature review,” Journal of Bone and Joint Surgery—Series A, vol. 92, no. 12, pp. 2165–2170, 2010. View at Publisher · View at Google Scholar · View at Scopus
  226. E. P. Vichinsky, L. D. Neumayr, C. Haberkern et al., “The perioperative complication rate of orthopedic surgery in sickle cell disease: report of the National Sickle Cell Surgery Study Group,” American Journal of Hematology, vol. 62, no. 3, pp. 129–138, 1999. View at Google Scholar
  227. G. A. Marulanda, C. P. Minniti, S. D. Ulrich, T. M. Seyler, and M. A. Mont, “Perioperative management for orthopaedic patients with sickle cell anaemia,” Journal of Orthopaedic Surgery (Hong Kong), vol. 17, no. 3, pp. 346–350, 2009. View at Google Scholar · View at Scopus
  228. E. P. Vichinsky, C. M. Haberkern, L. Neumayr et al., “A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease,” The New England Journal of Medicine, vol. 333, no. 4, pp. 206–213, 1995. View at Publisher · View at Google Scholar · View at Scopus
  229. M. Koshy, S. J. Weiner, S. T. Miller et al., “Surgery and anesthesia in sickle cell disease,” Blood, vol. 86, no. 10, pp. 3676–3684, 1995. View at Google Scholar · View at Scopus
  230. M. Mukisi-Mukaza, O. Manicom, C. Alexis, K. Bashoun, M. Donkerwolcke, and F. Burny, “Treatment of Sickle cell disease's hip necrosis by core decompression: a prospective case-control study,” Orthopaedics and Traumatology, vol. 95, no. 7, pp. 498–504, 2009. View at Publisher · View at Google Scholar · View at Scopus
  231. L. Massari, M. Fini, R. Cadossi, S. Setti, and G. C. Traina, “Biophysical stimulation with pulsed electromagnetic fields in osteonecrosis of the femoral head,” Journal of Bone and Joint Surgery—Series A, vol. 88, no. 3, supplement, pp. 56–60, 2006. View at Publisher · View at Google Scholar · View at Scopus
  232. C. J. Wang, F. S. Wang, C. C. Huang, K. D. Yang, L. H. Weng, and H. Y. Huang, “Treatment for osteonecrosis of the femoral head: comparison of extracorporeal shock waves with core decompression and bone-grafting,” Journal of Bone and Joint Surgery—Series A, vol. 87, no. 11, pp. 2380–2387, 2005. View at Publisher · View at Google Scholar · View at Scopus
  233. P. Hernigou, A. Poignard, S. Zilber, and H. Rouard, “Cell therapy of hip osteonecrosis with autologous bone marrow grafting,” Indian Journal of Orthopaedics, vol. 43, no. 1, pp. 40–45, 2009. View at Publisher · View at Google Scholar · View at Scopus
  234. B. Fink, T. Schneider, S. Conrad, M. Jaeger, M. Protzen, and W. Rüther, “The thrust plate prosthesis in patients with aseptic osteonecrosis of the femoral head,” Archives of Orthopaedic and Trauma Surgery, vol. 122, no. 9-10, pp. 499–505, 2002. View at Google Scholar · View at Scopus
  235. R. Elke and E. Morscher, “Total prosthesis arthroplasty in necrosis of the femoral head,” Orthopade, vol. 19, no. 4, pp. 236–241, 1990. View at Google Scholar · View at Scopus
  236. P. Hernigou, S. Zilber, P. Filippini, G. Mathieu, A. Poignard, and F. Galacteros, “Total THA in adult osteonecrosis related to sickle cell disease,” Clinical Orthopaedics and Related Research, vol. 466, no. 2, pp. 300–308, 2008. View at Publisher · View at Google Scholar · View at Scopus
  237. K.M. Mahadeo, S. Oyeku, B. Taragin et al., “Increased prevalence of osteonecrosis of the femoral head in children and adolescents with sickle-cell disease,” American Journal of Hematology, vol. 86, no. 9, pp. 806–808, 2011. View at Google Scholar
  238. Z. R. Rogers, “Hydroxyurea therapy for diverse pediatric populations with sickle cell disease,” Seminars in hematology, vol. 34, no. 3, supplement 3, pp. 42–47, 1997. View at Google Scholar · View at Scopus
  239. A. Kattamis, E. Lagona, I. Orfanou et al., “Clinical response and adverse events in young patients with sickle cell disease treated with hydroxyurea,” Pediatric Hematology and Oncology, vol. 21, no. 4, pp. 335–342, 2004. View at Publisher · View at Google Scholar · View at Scopus
  240. B. Gulbis, D. Haberman, D. Dufour et al., “Hydroxyurea for sickle cell disease in children and for prevention of cerebrovascular events: the Belgian experience,” Blood, vol. 105, no. 7, pp. 2685–2690, 2005. View at Publisher · View at Google Scholar · View at Scopus
  241. C. M. Aguilar, L. D. Neumayr, B. E. Eggleston et al., “Clinical evaluation of avascular necrosis in patients with sickle cell disease: children's hospital oakland hip evaluation scale—a modification of the harris hip score,” Archives of Physical Medicine and Rehabilitation, vol. 86, no. 7, pp. 1369–1375, 2005. View at Publisher · View at Google Scholar · View at Scopus
  242. M. Koshy, R. Entsuah, A. Koranda et al., “Leg ulcers in patients with sickle cell disease,” Blood, vol. 74, no. 4, pp. 1403–1408, 1989. View at Google Scholar · View at Scopus
  243. M. Halabi-Tawil, F. Lionnet, R. Girot, C. Bachmeyer, P. P. Lévy, and S. Aractingi, “Sickle cell leg ulcers: a frequently disabling complication and a marker of severity,” British Journal of Dermatology, vol. 158, no. 2, pp. 339–344, 2008. View at Publisher · View at Google Scholar · View at Scopus
  244. V. Cumming, L. King, R. Fraser, G. Serjeant, and M. Reid, “Venous incompetence, poverty and lactate dehydrogenase in Jamaica are important predictors of leg ulceration in sickle cell anaemia,” British Journal of Haematology, vol. 142, no. 1, pp. 119–125, 2008. View at Publisher · View at Google Scholar · View at Scopus
  245. G. J. Kato, V. McGowan, R. F. Machado et al., “Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease,” Blood, vol. 107, no. 6, pp. 2279–2285, 2006. View at Publisher · View at Google Scholar · View at Scopus
  246. J. R. Eckman, “Leg ulcers in sickle cell disease,” Hematology/Oncology Clinics of North America, vol. 10, no. 6, pp. 1333–1344, 1996. View at Google Scholar · View at Scopus
  247. V. G. Nolan, A. Adewoye, C. Baldwin et al., “Sickle cell leg ulcers: associations with haemolysis and SNPs in Klotho, TEK and genes of the TGF-β/BMP pathway,” British Journal of Haematology, vol. 133, no. 5, pp. 570–578, 2006. View at Publisher · View at Google Scholar · View at Scopus
  248. J. S. Mohan, J. E. Vigilance, J. M. Marshall, I. R. Hambleton, H. L. Reid, and G. R. Serjeant, “Abnormal venous function in patients with homozygous sickle cell (SS) disease and chronic leg ulcers,” Clinical Science, vol. 98, no. 6, pp. 667–672, 2000. View at Google Scholar · View at Scopus
  249. C. P. Minniti, J. Eckman, P. Sebastiani, M. H. Steinberg, and S. K. Ballas, “Leg ulcers in sickle cell disease,” American Journal of Hematology, vol. 85, no. 10, pp. 831–833, 2010. View at Publisher · View at Google Scholar · View at Scopus
  250. G. R. Serjeant, R. E. Galloway, and M. C. Gueri, “Oral zinc sulphate in sickle-cell ulcers,” The Lancet, vol. 2, no. 7679, pp. 891–892, 1970. View at Google Scholar · View at Scopus
  251. N. Weinzweig, J. Schuler, M. Marschall, and M. Koshy, “Lower limb salvage by microvascular free tissue transfer in patients with homozygous sickle cell disease,” Plastic and Reconstructive Surgery, vol. 96, no. 5, pp. 1154–1161, 1995. View at Google Scholar · View at Scopus
  252. C. S. Burton, “Treatment of leg ulcers,” Dermatologic Clinics, vol. 11, no. 2, pp. 315–323, 1993. View at Google Scholar · View at Scopus
  253. K. F. Baum, D. E. MacFarlane, G. H. Maude, and G. R. Serjeant, “Topical antibiotics in chronic sickle cell leg ulcers,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 81, no. 5, pp. 847–849, 1987. View at Google Scholar · View at Scopus
  254. A. S. Prasad, “Zinc deficiency in patients with sickle cell disease,” American Journal of Clinical Nutrition, vol. 75, no. 2, pp. 181–182, 2002. View at Google Scholar · View at Scopus
  255. S. K. Ballas, “Treatment of painful sickle cell leg ulcers with topical opioids,” Blood, vol. 99, no. 3, p. 1096, 2002. View at Publisher · View at Google Scholar · View at Scopus
  256. D. L. Steed, M. W. Webster, J. J. Ricotta et al., “Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers,” Journal of Vascular Surgery, vol. 21, no. 1, pp. 71–81, 1995. View at Publisher · View at Google Scholar · View at Scopus
  257. D. L. Goldenberg and J. I. Reed, “Bacterial arthritis,” The New England Journal of Medicine, vol. 312, no. 12, pp. 764–771, 1985. View at Google Scholar · View at Scopus
  258. P. Hernigou, G. Daltro, C. H. Flouzat-Lachaniette, X. Roussignol, and A. Poignard, “Septic arthritis in adults with sickle cell disease often is associated with osteomyelitis or osteonecrosis,” Clinical Orthopaedics and Related Research, vol. 468, no. 6, pp. 1676–1681, 2010. View at Publisher · View at Google Scholar · View at Scopus
  259. M. G. Neonato, M. Guilloud-Bataille, P. Beauvais et al., “Acute clinical events in 299 homozygous sickle cell patients living in france,” European Journal of Haematology, vol. 65, no. 3, pp. 155–164, 2000. View at Publisher · View at Google Scholar · View at Scopus
  260. A. J. Anand and A. E. Glatt, “Salmonella osteomyelitis and arthritis in sickle cell disease,” Seminars in Arthritis and Rheumatism, vol. 24, no. 3, pp. 211–221, 1994. View at Google Scholar · View at Scopus
  261. M. W. Burnett, J. W. Bass, and B. A. Cook, “Etiology of osteomyelitis complicating sickle cell disease,” Pediatrics, vol. 101, no. 2, pp. 296–297, 1998. View at Publisher · View at Google Scholar · View at Scopus
  262. K. Keeley and G. R. Buchanan, “Acute infarction of long bones in children with sickle cell anemia,” Journal of Pediatrics, vol. 101, no. 2, pp. 170–175, 1982. View at Google Scholar · View at Scopus
  263. J. B. Chambers, D. A. Forsythe, S. L. Bertrand, H. J. Iwinski, and D. E. Steflik, “Retrospective review of osteoarticular infections in a pediatric sickle cell age group,” Journal of Pediatric Orthopaedics, vol. 20, no. 5, pp. 682–685, 2000. View at Publisher · View at Google Scholar · View at Scopus
  264. M. Sadat-Ali, D. Ortho, K. Al-Umran, I. Al-Habdan, and F. Al-Mulhim, “Ultrasonography: can it differentiate between vasoocclusive crisis and acute osteomyelitis in sickle cell disease?” Journal of Pediatric Orthopaedics, vol. 18, no. 4, pp. 552–554, 1998. View at Publisher · View at Google Scholar · View at Scopus
  265. A. Rifai and R. Nyman, “Scintigraphy and ultrasonography in differentiating osteomyelitis from bone infarction in sickle cell disease,” Acta Radiologica, vol. 38, no. 1, pp. 139–143, 1997. View at Google Scholar · View at Scopus
  266. J. E. Stark, C. M. Glasier, R. D. Blasier, J. Aronson, and J. J. Seibert, “Osteomyelitis in children with sickle cell disease: early diagnosis with contrast-enhanced CT,” Radiology, vol. 179, no. 3, pp. 731–733, 1991. View at Google Scholar · View at Scopus
  267. R. R. William, S. S. Hussein, W. D. Jeans, Y. A. Wali, and Z. A. Lamki, “A prospective study of soft-tissue ultrasonography in sickle cell disease patients with suspected osteomyelitis,” Clinical Radiology, vol. 55, no. 4, pp. 307–310, 2000. View at Publisher · View at Google Scholar · View at Scopus
  268. P. J. Amrolia, A. Almeida, S. C. Davies, and I. A. G. Roberts, “Therapeutic challenges in childhood sickle cell disease. Part 2: a problem-orientated approach,” British Journal of Haematology, vol. 120, no. 5, pp. 737–743, 2003. View at Publisher · View at Google Scholar · View at Scopus
  269. P. J. Amrolia, A. Almeida, C. Halsey, I. A. G. Roberts, and S. C. Davies, “Therapeutic challenges in childhood sickle cell disease Part 1: current and future treatment options,” British Journal of Haematology, vol. 120, no. 5, pp. 725–736, 2003. View at Publisher · View at Google Scholar · View at Scopus
  270. C. H. Epps Jr., D. D. Bryant III, M. J. M. Coles, and O. Castro, “Osteomyelitis in patients who have sickle-cell disease. Diagnosis and management,” Journal of Bone and Joint Surgery—Series A, vol. 73, no. 9, pp. 1281–1294, 1991. View at Google Scholar · View at Scopus
  271. E. Barrett-Connor, “Bacterial infection and sickle cell anemia. An analysis of 250 infections in 166 patients and a review of the literature,” Medicine, vol. 50, no. 2, pp. 97–112, 1971. View at Google Scholar · View at Scopus
  272. W. W. Ebong, “Septic arthritis in patients with sickle-cell disease,” British Journal of Rheumatology, vol. 26, no. 2, pp. 99–102, 1987. View at Google Scholar · View at Scopus
  273. K. Ohene-Frempong, S. J. Weiner, L. A. Sleeper et al., “Cerebrovascular accidents in sickle cell disease: rates and risk factors,” Blood, vol. 91, no. 1, pp. 288–294, 1998. View at Google Scholar · View at Scopus
  274. H. J. Fullerton, R. J. Adams, S. Zhao, and S. C. Johnston, “Declining stroke rates in Californian children with sickle cell disease,” Blood, vol. 104, no. 2, pp. 336–339, 2004. View at Publisher · View at Google Scholar · View at Scopus
  275. M. B. McCarville, G. S. Goodin, G. Fortner et al., “Evaluation of a comprehensive transcranial Doppler screening program for children with sickle cell anemia,” Pediatric Blood and Cancer, vol. 50, no. 4, pp. 818–821, 2008. View at Publisher · View at Google Scholar · View at Scopus
  276. H. Enninful-Eghan, R. H. Moore, R. Ichord, K. Smith-Whitley, and J. L. Kwiatkowski, “Transcranial Doppler ultrasonography and prophylactic transfusion program is effective in preventing overt stroke in children with sickle cell disease,” Journal of Pediatrics, vol. 157, no. 3, pp. 479–484, 2010. View at Publisher · View at Google Scholar · View at Scopus
  277. J. D. Lebensburger, L. M. Hilliard, T. M. McGrath, N. S. Fineberg, and T. H. Howard, “Laboratory and clinical correlates for magnetic resonance imaging (MRI) abnormalities in pediatric sickle cell anemia,” Journal of Child Neurology, vol. 26, no. 10, pp. 1260–1264, 2012. View at Google Scholar
  278. P. C. Hines, T. P. McKnight, W. Seto, and J. L. Kwiatkowski, “Central nervous system events in children with sickle cell disease presenting acutely with headache,” Journal of Pediatrics, vol. 159, no. 3, pp. 472–478, 2011. View at Publisher · View at Google Scholar · View at Scopus
  279. B. Aygun, M. A. McMurray, W. H. Schultz et al., “Chronic transfusion practice for children with sickle cell anaemia and stroke,” British Journal of Haematology, vol. 145, no. 4, pp. 524–528, 2009. View at Publisher · View at Google Scholar · View at Scopus
  280. P. B. Walter, P. Harmatz, and E. Vichinsky, “Iron metabolism and iron chelation in sickle cell disease,” Acta Haematologica, vol. 122, no. 2-3, pp. 174–183, 2009. View at Publisher · View at Google Scholar · View at Scopus
  281. C. H. Pegelow, R. J. Adams, V. McKie et al., “Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions,” Journal of Pediatrics, vol. 126, no. 6, pp. 896–899, 1995. View at Google Scholar · View at Scopus
  282. D. J. Scothorn, C. Price, D. Schwartz et al., “Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke,” Journal of Pediatrics, vol. 140, no. 3, pp. 348–354, 2002. View at Publisher · View at Google Scholar · View at Scopus
  283. M. L. Hulbert, R. C. McKinstry, J. L. Lacey et al., “Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease,” Blood, vol. 117, no. 3, pp. 772–779, 2011. View at Publisher · View at Google Scholar · View at Scopus
  284. D. Powars, B. Wilson, C. Imbus, C. Pegelow, and J. Allen, “The natural history of stroke in sickle cell disease,” American Journal of Medicine, vol. 65, no. 3, pp. 461–471, 1978. View at Google Scholar · View at Scopus
  285. R. J. Adams, “Stroke prevention in sickle cell disease,” Current Opinion in Hematology, vol. 7, no. 2, pp. 101–105, 2000. View at Publisher · View at Google Scholar · View at Scopus
  286. R. E. Ware and R. W. Helms, “Stroke with transfusion changing to hydroxyurea (SWiTCH): a phase 3 randomized clinical trial for treatment of children with sickle cell anemia, previous stroke, and iron overload,” Blood, vol. 116, article 367a, 2010. View at Google Scholar
  287. F. Bernaudin, S. Verlhac, C. Arnaud et al., “Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort,” Blood, vol. 117, no. 4, pp. 1130–1140, 2011. View at Publisher · View at Google Scholar · View at Scopus
  288. R. J. Adams and D. Brambilla, “Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease,” The New England Journal of Medicine, vol. 353, no. 26, pp. 2769–2778, 2005. View at Publisher · View at Google Scholar · View at Scopus
  289. S. A. Zimmerman, W. H. Schultz, S. Burgett, N. A. Mortier, and R. E. Ware, “Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemia,” Blood, vol. 110, no. 3, pp. 1043–1047, 2007. View at Publisher · View at Google Scholar · View at Scopus
  290. N. Lefèvre, D. Dufour, B. Gulbis, P. Q. Lê, C. Heijmans, and A. Ferster, “Use of hydroxyurea in prevention of stroke in children with sickle cell disease,” Blood, vol. 111, no. 2, pp. 963–964, 2008. View at Publisher · View at Google Scholar · View at Scopus
  291. J. Rothman, S. Burgett, R. E. Ware, and C. Thornburg, “Hydroxyurea reduces conversion from conditional to abnormal TCD velocities in children with sickle cell anemia (SCA),” Blood, vol. 116, article 123a, 2010. View at Google Scholar
  292. F. D. Armstrong, R. J. Thompson Jr., M. D. Winfred Wang et al., “Cognitive functioning and brain magnetic resonance imaging in children with sickle cell disease,” Pediatrics, vol. 97, no. 6, pp. 864–870, 1996. View at Google Scholar · View at Scopus
  293. C. H. Pegelow, E. A. Macklin, F. G. Moser et al., “Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease,” Blood, vol. 99, no. 8, pp. 3014–3018, 2002. View at Publisher · View at Google Scholar · View at Scopus
  294. W. Wang, L. Enos, D. Gallagher et al., “Neuropsychologic performance in school-aged children with sickle cell disease: a report from the Cooperative Study of Sickle Cell Disease,” Journal of Pediatrics, vol. 139, no. 3, pp. 391–397, 2001. View at Publisher · View at Google Scholar · View at Scopus
  295. J. S. Hankins, K. J. Helton, M. B. McCarville, C. S. Li, W. C. Wang, and R. E. Ware, “Preservation of spleen and brain function in children with sickle cell anemia treated with hydroxyurea,” Pediatric Blood and Cancer, vol. 50, no. 2, pp. 293–297, 2008. View at Publisher · View at Google Scholar · View at Scopus
  296. M. C. Walters, R. Storb, M. Patience et al., “Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report,” Blood, vol. 95, no. 6, pp. 1918–1924, 2000. View at Google Scholar · View at Scopus
  297. P. Woodard, K. J. Helton, R. B. Khan et al., “Brain parenchymal damage after haematopoietic stem cell transplantation for severe sickle cell disease,” British Journal of Haematology, vol. 129, no. 4, pp. 550–552, 2005. View at Publisher · View at Google Scholar · View at Scopus
  298. J. Schatz and C. B. McClellan, “Sickle cell disease as a neurodevelopmental disorder,” Mental Retardation and Developmental Disabilities Research Reviews, vol. 12, no. 3, pp. 200–207, 2006. View at Publisher · View at Google Scholar · View at Scopus
  299. L. D. Berkelhammer, A. L. Williamson, S. D. Sanford et al., “Neurocognitive sequelae of pediatric sickle cell disease: a review of the literature,” Child Neuropsychology, vol. 13, no. 2, pp. 120–131, 2007. View at Publisher · View at Google Scholar · View at Scopus
  300. B. Daly, M. C. Kral, and R. A. Tarazi, “The role of neuropsychological evaluation in pediatric sickle cell disease,” Clinical Neuropsychologist, vol. 25, no. 6, pp. 903–925, 2011. View at Publisher · View at Google Scholar
  301. E. P. Vichinsky, L. D. Neumayr, J. I. Gold et al., “Neuropsychological dysfunction and neuroimaging abnormalities in neurologically intact adults with sickle cell anemia,” JAMA: Journal of the American Medical Association, vol. 303, no. 18, pp. 1823–1831, 2010. View at Publisher · View at Google Scholar · View at Scopus
  302. N. Scantlebury, D. Mabbott, L. Janzen et al., “White matter integrity and core cognitive function in children diagnosed with sickle cell disease,” Journal of Pediatric Hematology/Oncology, vol. 33, no. 3, pp. 163–171, 2011. View at Publisher · View at Google Scholar · View at Scopus
  303. M. C. Kral, R. T. Brown, P. J. Nietert, M. R. Abboud, S. M. Jackson, and G. W. Hynd, “Transcranial Doppler ultrasonography and neurocognitive functioning in children with Sickle Cell disease,” Pediatrics, vol. 112, no. 2, pp. 324–331, 2003. View at Publisher · View at Google Scholar · View at Scopus
  304. C. E. Sanchez, J. Schatz, and C. W. Roberts, “Cerebral blood flow velocity and language functioning in pediatric sickle cell disease,” Journal of the International Neuropsychological Society, vol. 16, no. 2, pp. 326–334, 2010. View at Publisher · View at Google Scholar · View at Scopus
  305. J. J. Strouse, C. S. Cox, E. R. Melhem et al., “Inverse correlation between cerebral blood flow measured by continuous arterial spin-labeling (CASL) MRI and neurocognitive function in children with sickle cell anemia (SCA),” Blood, vol. 108, no. 1, pp. 379–381, 2006. View at Publisher · View at Google Scholar · View at Scopus
  306. E. Puffer, J. Schatz, and C. W. Roberts, “The association of oral hydroxyurea therapy with improved cognitive functioning in sickle cell disease,” Child Neuropsychology, vol. 13, no. 2, pp. 142–154, 2007. View at Publisher · View at Google Scholar · View at Scopus
  307. A. A. King, D. A. White, R. C. McKinstry, M. Noetzel, and M. R. DeBaun, “A pilot randomized education rehabilitation trial is feasible in sickle cell and strokes,” Neurology, vol. 68, no. 23, pp. 2008–2011, 2007. View at Publisher · View at Google Scholar · View at Scopus
  308. A. M. Hogan, F. J. Kirkham, E. B. Isaacs, A. M. Wade, and F. Vargha-Khadem, “Intellectual decline in children with moyamoya and sickle cell anaemia,” Developmental Medicine and Child Neurology, vol. 47, no. 12, pp. 824–829, 2005. View at Publisher · View at Google Scholar · View at Scopus
  309. S. R. Dobson, K. R. Holden, P. J. Nietert et al., “Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events,” Blood, vol. 99, no. 9, pp. 3144–3150, 2002. View at Publisher · View at Google Scholar · View at Scopus
  310. T. C. Hankinson, L. E. Bohman, G. Heyer et al., “Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarteriosynangiosis,” Journal of Neurosurgery, vol. 1, no. 3, pp. 211–216, 2008. View at Publisher · View at Google Scholar · View at Scopus
  311. E. R. Smith, C. D. McClain, M. Heeney, and R. M. Scott, “Pial synangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome,” Neurosurgical Focus, vol. 26, no. 4, pp. 1–8, 2009. View at Publisher · View at Google Scholar · View at Scopus
  312. G. G. Emerson and G. A. Lutty, “Effects of sickle cell disease on the eye: clinical features and treatment,” Hematology/Oncology Clinics of North America, vol. 19, no. 5, pp. 957–973, 2005. View at Publisher · View at Google Scholar · View at Scopus
  313. A. Ganesh, R. R. William, S. Mitra et al., “Orbital involvement in sickle cell disease: a report of five cases and review literature,” Eye, vol. 15, no. 6, pp. 774–780, 2001. View at Google Scholar · View at Scopus
  314. A. Dixit, T. C. Chatterjee, M. Papneja et al., “Sickle beta-thalassemia presenting as orbital compression syndrome,” Annals of Hematology, vol. 83, no. 8, pp. 536–540, 2004. View at Google Scholar · View at Scopus
  315. E. L. Curran, J. C. Fleming, K. Rice, and W. C. Wang, “Orbital compression syndrome in sickle cell disease,” Ophthalmology, vol. 104, no. 10, pp. 1610–1615, 1997. View at Google Scholar · View at Scopus
  316. J. A. Sokol, E. Baron, G. Lantos, and M. Kazim, “Orbital compression syndrome in sickle cell disease,” Ophthalmic Plastic and Reconstructive Surgery, vol. 24, no. 3, pp. 181–184, 2008. View at Publisher · View at Google Scholar · View at Scopus
  317. D. Paton, “The conjunctival sign of sickle-cell disease,” Archives of Ophthalmology, vol. 66, pp. 90–94, 1961. View at Google Scholar · View at Scopus
  318. C. S. P. Lima, E. M. Rocha, N. M. Silva, M. F. Sonatti, F. F. Costa, and S. T. O. Saad, “Risk factors for conjunctival and retinal vessel alterations in sickle cell disease,” Acta Ophthalmologica Scandinavica, vol. 84, no. 2, pp. 234–241, 2006. View at Publisher · View at Google Scholar · View at Scopus
  319. A. I. Fink, T. Funahashi, M. Robinson, and R. J. WATSON, “Conjunctival blood flow in sickle-cell disease. Preliminary report,” Archives of Ophthalmology, vol. 66, pp. 824–829, 1961. View at Google Scholar · View at Scopus
  320. K. C. Nagpal, M. F. Goldberg, and M. F. Rabb, “Ocular manifestations of sickle hemoglobinopathies,” Survey of Ophthalmology, vol. 21, no. 5, pp. 391–411, 1977. View at Google Scholar · View at Scopus
  321. T. Funahashi, A. Fink, M. Robinson, and R. J. Watson, “Pathology of conjunctival vessels in sickle-cell disease. A preliminary report,” American Journal of Ophthalmology, vol. 57, no. 5, pp. 713–718, 1964. View at Google Scholar · View at Scopus
  322. R. L. Bergren and G. C. Brown, “Neovascular glaucoma secondary to sickle-cell retinopathy,” American Journal of Ophthalmology, vol. 113, no. 6, pp. 718–719, 1992. View at Google Scholar · View at Scopus
  323. M. F. Goldberg and M. O. M. Tso, “Rubeosis iridis and glaucoma associated with sickle cell retinopathy: a light and electron microscopic study,” Ophthalmology, vol. 85, no. 10, pp. 1028–1041, 1978. View at Google Scholar · View at Scopus
  324. T. A. Deutsch, R. N. Weinreb, and M. F. Goldberg, “Indications for surgical management of hyphema in patients with sickle cell trait,” Archives of Ophthalmology, vol. 102, no. 4, pp. 566–569, 1984. View at Google Scholar · View at Scopus
  325. M. F. Goldberg, “The diagnosis and treatment of secondary glaucoma after hyphema in sickle cell patients,” American Journal of Ophthalmology, vol. 87, no. 1, pp. 43–49, 1979. View at Google Scholar · View at Scopus
  326. M. F. Goldberg, “The diagnosis and treatment of sickled erythrocytes in human hyphemas,” Transactions of the American Ophthalmological Society, vol. 76, pp. 481–501, 1978. View at Google Scholar · View at Scopus
  327. K. Karaman, S. Čulić, I. Erceg et al., “Treatment of post-traumatic trabecular mashwork thrombosis and secondary glaucoma with intracameral tissue plasminogen activator in previously unrecognized sickle cell anemia,” Collegium Antropologicum, vol. 29, no. 1, supplement, pp. 123–126, 2005. View at Google Scholar · View at Scopus
  328. J. D. Benner, “Transcorneal oxygen therapy for glaucoma associated with sickle cell hyphema,” American Journal of Ophthalmology, vol. 130, no. 4, pp. 514–515, 2000. View at Publisher · View at Google Scholar · View at Scopus
  329. N. Romayanada , M. F. Goldberg, and W. R. Green, “Histopathology of sickle cell retinopathy,” Transactions—American Academy of Ophthalmology and Otolaryngology, vol. 77, no. 5, pp. OP642–OP676, 1973. View at Google Scholar
  330. D. A. Gagliano and M. F. Goldberg, “The evolution of salmon-patch hemorrhages in sickle cell retinopathy,” Archives of Ophthalmology, vol. 107, no. 12, pp. 1814–1815, 1989. View at Google Scholar · View at Scopus
  331. J. C. Liang and L. M. Jampol, “Spontaneous peripheral chorioretinal neovascularisation in association with sickle cell anaemia,” British Journal of Ophthalmology, vol. 67, no. 2, pp. 107–110, 1983. View at Google Scholar · View at Scopus
  332. D. S. McLeod, M. F. Goldberg, and G. A. Lutty, “Dual-perspective analysis of vascular formations in sickle cell retinopathy,” Archives of Ophthalmology, vol. 111, no. 9, pp. 1234–1245, 1993. View at Google Scholar · View at Scopus
  333. D. S. McLeod, C. Merges, A. Fukushima, M. F. Goldberg, and G. A. Lutty, “Histopathologic features of neovascularization in sickle cell retinopathy,” American Journal of Ophthalmology, vol. 124, no. 4, pp. 455–472, 1997. View at Google Scholar · View at Scopus
  334. P. I. Condon, G. R. Serjeant, and H. Ikeda, “Unusual chorioretinal degeneration in sickle cell disease. Possible sequelae of posterior ciliary vessel occlusion,” British Journal of Ophthalmology, vol. 57, no. 2, pp. 81–88, 1973. View at Google Scholar · View at Scopus
  335. M. R. Stein and A. J. Gay, “Acute chorioretinal infarction in sickle cell trait. Report of a case,” Archives of Ophthalmology, vol. 84, no. 4, pp. 485–490, 1970. View at Google Scholar · View at Scopus
  336. M. H. Goldbaum, “Retinal depression sign indicating a small retinal infarct,” American Journal of Ophthalmology, vol. 86, no. 1, pp. 45–55, 1978. View at Google Scholar · View at Scopus
  337. D. Huang, E. A. Swanson, C. P. Lin et al., “Optical coherence tomography,” Science, vol. 254, no. 5035, pp. 1178–1181, 1991. View at Google Scholar · View at Scopus
  338. A. J. Witkin, A. H. Rogers, T. H. Ko, J. G. Fujimoto, J. S. Schuman, and J. S. Duker, “Optical coherence tomography demonstration of macular infarction in sickle cell retinopathy,” Archives of Ophthalmology, vol. 124, no. 5, pp. 746–747, 2006. View at Google Scholar · View at Scopus
  339. R. K. Murthy, S. Grover, and K. V. Chalam, “Temporal macular thinning on spectral-domain optical coherence tomography in proliferative sickle cell retinopathy,” Archives of Ophthalmology, vol. 129, no. 2, pp. 247–249, 2011. View at Publisher · View at Google Scholar · View at Scopus
  340. N. A. Al-Abdulla, T. A. Haddock, J. B. Kerrison, and M. F. Goldberg, “Sickle cell disease presenting with extensive peri-macular arteriolar occlusions in a nine-year-old boy,” American Journal of Ophthalmology, vol. 131, no. 2, pp. 275–276, 2001. View at Publisher · View at Google Scholar · View at Scopus
  341. I. Acacio and M. F. Goldberg, “Peripapillary and macular vessel occlusions in sickle cell anemia,” American Journal of Ophthalmology, vol. 75, no. 5, pp. 861–866, 1973. View at Google Scholar · View at Scopus
  342. C. M. Lee, H. C. Charles, and R. T. Smith, “Quantification of macular ischaemia in sickle cell retinopathy,” British Journal of Ophthalmology, vol. 71, no. 7, pp. 540–545, 1987. View at Google Scholar · View at Scopus
  343. M. Raichand, R. V. Dizon, and K. C. Nagpal, “Macular holes associated with proliferative sickle cell retinopathy,” Archives of Ophthalmology, vol. 96, no. 9, pp. 1592–1596, 1978. View at Google Scholar · View at Scopus
  344. H. D. Schubert, “Schisis in sickle cell retinopathy,” Archives of Ophthalmology, vol. 123, no. 11, pp. 1607–1609, 2005. View at Publisher · View at Google Scholar · View at Scopus
  345. M. H. Goldbaum, L. M. Jampol, and M. F. Goldberg, “The disc sign in sickling hemoglobinopathies,” Archives of Ophthalmology, vol. 96, no. 9, pp. 1597–1600, 1978. View at Google Scholar · View at Scopus
  346. M. F. Goldberg, “Retinal neovascularization in sickle cell retinopathy,” Transactions—American Academy of Ophthalmology and Otolaryngology, vol. 83, no. 3, pp. OP409–431, 1977. View at Google Scholar · View at Scopus
  347. M. Raichand, M. F. Goldberg, and K. C. Nagpal, “Evolution of neovascularization in sickle cell retinopathy. A prospective fluorescein angiographic study,” Archives of Ophthalmology, vol. 95, no. 9, pp. 1543–1552, 1977. View at Google Scholar · View at Scopus
  348. O. E. Babalola and C. O. Wambebe, “Ocular morbidity from sickle cell disease in a Nigerian cohort,” The Nigerian Postgraduate Medical Journal, vol. 12, no. 4, pp. 241–244, 2005. View at Google Scholar · View at Scopus
  349. M. Elagouz, S. Jyothi, B. Gupta, and S. Sivaprasad, “Sickle cell disease and the eye: old and new concepts,” Survey of Ophthalmology, vol. 55, no. 4, pp. 359–377, 2010. View at Publisher · View at Google Scholar · View at Scopus
  350. M. F. Goldberg, “Natural history of untreated proliferative sickle retinopathy,” Archives of Ophthalmology, vol. 85, no. 4, pp. 428–437, 1971. View at Google Scholar · View at Scopus
  351. G. Gao, Y. Li, D. Zhang, S. Gee, C. Crosson, and J. X. Ma, “Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization,” FEBS Letters, vol. 489, no. 2-3, pp. 270–276, 2001. View at Publisher · View at Google Scholar · View at Scopus
  352. S. Y. Kim, C. Mocanu, D. S. Mcleod et al., “Expression of pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in sickle cell retina and choroid,” Experimental Eye Research, vol. 77, no. 4, pp. 433–445, 2003. View at Publisher · View at Google Scholar · View at Scopus
  353. S. M. Downes, I. R. Hambleton, E. L. Chuang, N. Lois, G. R. Serjeant, and A. C. Bird, “Incidence and natural history of proliferative sickle cell retinopathy: observations from a cohort study,” Ophthalmology, vol. 112, no. 11, pp. 1869–1875, 2005. View at Publisher · View at Google Scholar · View at Scopus
  354. G. E. Emerson, J. B. Harlan, S. Fekrat, G. A. Lutty, and M. F. Goldberg, “Hemoglobinopathies,” Retina, vol. 2, pp. 1429–1445, 2006. View at Google Scholar
  355. S. B. Cohen, M. E. Fletcher, M. F. Goldberg, and N. J. Jednock, “Diagnosis and management of ocular complications of sickle hemoglobinopathies: part IV,” Ophthalmic Surgery, vol. 17, no. 5, pp. 312–315, 1986. View at Google Scholar · View at Scopus
  356. L. M. Jampol, J. L. Green, M. F. Goldberg, and G. A. Peyman, “An update on vitrectomy surgery and retinal detachment repair in sickle cell disease,” Archives of Ophthalmology, vol. 100, no. 4, pp. 591–593, 1982. View at Google Scholar · View at Scopus
  357. M. F. Goldberg and L. M. Jampol, “Treatment of neovascularization, vitreous hemorrhage, and retinal detachment in sickle cell retinopathy,” Transactions of the New Orleans Academy of Ophthalmology, vol. 31, pp. 53–81, 1983. View at Google Scholar · View at Scopus
  358. M. H. Goldbaum, G. A. Peyman, and K. C. Nagpal, “Vitrectomy in sickling retinopathy: report of five cases,” Ophthalmic Surgery, vol. 7, no. 4, pp. 92–102, 1976. View at Google Scholar · View at Scopus
  359. M. S. Jacobson, D. A. Gagliano, S. B. Cohen et al., “A randomized clinical trial of feeder vessel photocoagulation of sickle cell retinopathy: a long-term follow-up,” Ophthalmology, vol. 98, no. 5, pp. 581–585, 1991. View at Google Scholar · View at Scopus
  360. R. V. Dizon-Moore, L. M. Jampol, and M. F. Goldberg, “Chorioretinal and choriovitreal neovacularization. Their presence after photocoagulation of proliferative sickle cell retinopathy,” Archives of Ophthalmology, vol. 99, no. 5, pp. 842–849, 1981. View at Google Scholar · View at Scopus
  361. L. M. Jampol, M. Farber, M. F. Rabb, and G. Serjeant, “An update on techniques of photocoagulation treatment of proliferative sickle cell retinopathy,” Eye, vol. 5, no. 2, pp. 260–263, 1991. View at Google Scholar · View at Scopus
  362. M. Cho and S. Kiss, “Detection and monitoring of sickle cell retinopathy using ultra wide-field color photography and fluorescein angiography,” Retina, vol. 31, no. 4, pp. 738–747, 2011. View at Publisher · View at Google Scholar · View at Scopus
  363. M. D. Farber, L. M. Jampol, P. Fox et al., “A randomized clinical trial of scatter photocoagulation of proliferative sickle cell retinopathy,” Archives of Ophthalmology, vol. 109, no. 3, pp. 363–367, 1991. View at Google Scholar · View at Scopus
  364. L. M. Jampol and M. F. Goldberg, “Retinal breaks after photocoagulation of proliferative sickle cell retinopathy,” Archives of Ophthalmology, vol. 98, no. 4, pp. 676–679, 1980. View at Google Scholar · View at Scopus
  365. A. S. Kimmel, L. E. Magargal, R. F. Stephens, and A. F. Cruess, “Peripheral circumferential retinal scatter photocoagulation for the treatment of proliferative sickle retinopathy: an update,” Ophthalmology, vol. 93, no. 11, pp. 1429–1432, 1986. View at Google Scholar · View at Scopus
  366. K. R. V. Rednam, I. M. Jampol, and M. F. Goldberg, “Scatter retinal photocoagulation for proliferative sickle cell retinopathy,” American Journal of Ophthalmology, vol. 93, no. 5, pp. 594–599, 1982. View at Google Scholar · View at Scopus
  367. V. Seiberth, “Trans-scleral diode laser photocoagulation in proliferative sickle cell retinopathy,” Ophthalmology, vol. 106, no. 9, pp. 1828–1829, 1999. View at Google Scholar · View at Scopus
  368. C. B. Lee, M. B. Woolf, and S. O. Galinos, “Cryotherapy of proliferative sickle retinopathy. I. Single freeze thaw cycle,” Annals of Ophthalmology, vol. 7, no. 10, pp. 1299–1308, 1975. View at Google Scholar · View at Scopus
  369. M. H. Goldbaum, R. C. Fletcher, L. M. Jampol, and M. F. Goldberg, “Cryotherapy of proliferative sickle retinopathy, II: triple freeze-thaw cycle,” British Journal of Ophthalmology, vol. 63, no. 2, pp. 97–101, 1979. View at Google Scholar · View at Scopus
  370. N. F. Hrisomalos, L. M. Jampol, and B. J. Moriarty, “Neodymium-YAG laser vitreolysis in sickle cell retinopathy,” Archives of Ophthalmology, vol. 105, no. 8, pp. 1087–1091, 1987. View at Google Scholar · View at Scopus
  371. L. M. Jampol, M. F. Goldberg, and N. Jednock, “Retinal damage from a Q-switched YAG laser,” American Journal of Ophthalmology, vol. 96, no. 3, pp. 326–329, 1983. View at Google Scholar · View at Scopus
  372. C. A. Puliafito, P. J. Wasson, R. F. Steinert, and E. S. Gragoudas, “Neodymium-YAG laser surgery on experimental vitreous membranes,” Archives of Ophthalmology, vol. 102, no. 6, pp. 843–847, 1984. View at Google Scholar · View at Scopus
  373. F. Fankhauser, S. Kwasniewska, and E. van der Zypen, “Vitreolysis with the Q-switched laser,” Archives of Ophthalmology, vol. 103, no. 8, pp. 1166–1171, 1985. View at Google Scholar · View at Scopus
  374. R. Rajagopal and R. S. Apte, “Full-thickness macular hole in a patient with proliferative sickle cell retinopathy,” Retina, vol. 30, no. 5, pp. 838–839, 2010. View at Publisher · View at Google Scholar · View at Scopus
  375. J. O. Mason III, “Surgical closure of macular hole in association with proliferative sickle cell retinopathy,” Retina, vol. 22, no. 4, pp. 501–502, 2002. View at Google Scholar · View at Scopus
  376. T. H. Williamson, R. Rajput, D. A. H. Laidlaw, and B. Mokete, “Vitreoretinal management of the complications of sickle cell retinopathy by observation or pars plana vitrectomy,” Eye, vol. 23, no. 6, pp. 1314–1320, 2009. View at Publisher · View at Google Scholar · View at Scopus
  377. S. J. Ryan and M. F. Goldberg, “Anterior segment ischemia following scleral buckling in sickle cell hemoglobinopathy,” American Journal of Ophthalmology, vol. 72, no. 1, pp. 35–50, 1971. View at Google Scholar · View at Scopus
  378. J. S. Leen, R. Ratnakaram, L. V. Del Priore, N. Bhagat, and M. A. Zarbin, “Anterior segment ischemia after vitrectomy in sickle cell disease,” Retina, vol. 22, no. 2, pp. 216–219, 2002. View at Publisher · View at Google Scholar · View at Scopus
  379. R. C. Siqueira, R. A. Costa, I. U. Scott, L. P. Cintra, and R. Jorge, “Intravitreal bevacizumab (Avastin) injection associated with regression of retinal neovascularization caused by sickle cell retinopathy,” Acta Ophthalmologica Scandinavica, vol. 84, no. 6, pp. 834–835, 2006. View at Publisher · View at Google Scholar · View at Scopus
  380. M. Kunz Mathews, D. S. McLeod, C. Merges, J. Cao, and G. A. Lutty, “Neutrophils and leucocyte adhesion molecules in sickle cell retinopathy,” British Journal of Ophthalmology, vol. 86, no. 6, pp. 684–690, 2002. View at Publisher · View at Google Scholar · View at Scopus
  381. J. S. Pober, “TNF as an activator of vascular endothelium,” Annales de l'Institut Pasteur, vol. 139, no. 3, pp. 317–323, 1988. View at Google Scholar · View at Scopus
  382. R. B. Francis Jr. and L. J. Haywood, “Elevated immunoreactive tumor necrosis factor and interleukin-1 in sickle cell disease,” Journal of the National Medical Association, vol. 84, no. 7, pp. 611–615, 1992. View at Google Scholar · View at Scopus
  383. C. C. Joneckis, R. L. Ackley, E. P. Orringer, E. A. Wayner, and L. V. Parise, “Integrin α4β1 and glycoprotein IV (CD36) are expressed on circulating reticulocytes in sickle cell anemia,” Blood, vol. 82, no. 12, pp. 3548–3555, 1993. View at Google Scholar · View at Scopus
  384. R. A. Swerlick, J. R. Eckman, A. Kumar, M. Jeitler, and T. M. Wick, “α4β1-Integrin expression on sickle reticulocytes: vascular cell adhesion molecule-1-dependent binding to endothelium,” Blood, vol. 82, no. 6, pp. 1891–1899, 1993. View at Google Scholar · View at Scopus
  385. G. A. Lutty, M. Taomoto, J. Cao et al., “Inhibition of TNF-α-induced sickle RBC retention in retina by a VLA-4 antagonist,” Investigative Ophthalmology and Visual Science, vol. 42, no. 6, pp. 1349–1355, 2001. View at Google Scholar · View at Scopus
  386. G. A. Lutty, T. Otsuji, M. Taomoto et al., “Mechanisms for sickle red blood cell retention in choroid,” Current Eye Research, vol. 25, no. 3, pp. 163–171, 2002. View at Publisher · View at Google Scholar · View at Scopus
  387. T. C. Griffin, D. Mcintire, and G. R. Buchanan, “High-dose intravenous methylprednisolone therapy for pain in children and adolescents with sickle cell disease,” The New England Journal of Medicine, vol. 330, no. 11, pp. 733–737, 1994. View at Publisher · View at Google Scholar · View at Scopus
  388. H. Ren, I. Obike, I. Okpala, K. Ghebremeskel, C. Ugochukwu, and M. Crawford, “Steady-state haemoglobin level in sickle cell anaemia increases with an increase in erythrocyte membrane n-3 fatty acids,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 72, no. 6, pp. 415–421, 2005. View at Publisher · View at Google Scholar · View at Scopus
  389. H. Ren, I. Okpala, K. Ghebremeskel, C. C. Ugochukwu, O. Ibegbulam, and M. Crawford, “Blood mononuclear cells and platelets have abnormal fatty acid composition in homozygous sickle cell disease,” Annals of Hematology, vol. 84, no. 9, pp. 578–583, 2005. View at Publisher · View at Google Scholar · View at Scopus
  390. A. Tomer, S. Kasey, W. E. Connor, S. Clark, L. A. Harker, and J. R. Eckman, “Reduction of pain episodes and prothrombotic activity in sickle cell disease by dietary n-3 fatty acids,” Thrombosis and Haemostasis, vol. 85, no. 6, pp. 966–974, 2001. View at Google Scholar · View at Scopus
  391. R. Bainbridge, D. R. Higgs, G. H. Maude, and G. R. Serjeant, “Clinical presentation of homozygous sickle cell disease,” Journal of Pediatrics, vol. 106, no. 6, pp. 881–885, 1985. View at Google Scholar · View at Scopus
  392. M. C. G. Stevens, M. Padwick, and G. R. Serjeant, “Observations on the natural history of dactylitis in homozygous sickle cell disease,” Clinical Pediatrics, vol. 20, no. 5, pp. 311–317, 1981. View at Google Scholar · View at Scopus
  393. K. Bailey, J. S. Morris, P. Thomas, and G. R. Serjeant, “Fetal haemoglobin and early manifestations of homozygous sickle cell disease,” Archives of Disease in Childhood, vol. 67, no. 4, pp. 517–520, 1992. View at Google Scholar · View at Scopus
  394. F. M. Gill, L. A. Sleeper, S. J. Weiner et al., “Clinical events in the first decade in a cohort of infants with sickle cell disease,” Blood, vol. 86, no. 2, pp. 776–783, 1995. View at Google Scholar · View at Scopus
  395. O. S. Platt, B. D. Thorington, D. J. Brambilla et al., “Pain in sickle cell disease—rates and risk factors,” The New England Journal of Medicine, vol. 325, no. 1, pp. 11–16, 1991. View at Google Scholar · View at Scopus
  396. C. Dampier, B. N. Y. Setty, B. Eggleston, D. Brodecki, P. O'Neal, and M. Stuart, “Vaso-occlusion in children with sickle cell disease: clinical characteristics and biologic correlates,” Journal of Pediatric Hematology/Oncology, vol. 26, no. 12, pp. 785–790, 2004. View at Google Scholar · View at Scopus
  397. S. Krishnan, Y. Setty, S. G. Betal et al., “Increased levels of the inflammatory biomarker C-reactive protein at baseline are associated with childhood sickle cell vasocclusive crises,” British Journal of Haematology, vol. 148, no. 5, pp. 797–804, 2010. View at Publisher · View at Google Scholar · View at Scopus
  398. F. A. Mohammed, N. Mahdi, M. A. Sater, K. Al-Ola, and W. Y. Almawi, “The relation of C-reactive protein to vasoocclusive crisis in children with sickle cell disease,” Blood Cells, Molecules, and Diseases, vol. 45, no. 4, pp. 293–296, 2010. View at Publisher · View at Google Scholar · View at Scopus
  399. C. Dampier, S. Lieff, P. LeBeau et al., “Health-related quality of life in children with sickle cell disease: a report from the comprehensive sickle cell centers clinical trial consortium,” Pediatric Blood and Cancer, vol. 55, no. 3, pp. 485–494, 2010. View at Publisher · View at Google Scholar · View at Scopus
  400. W. R. Smith, L. T. Penberthy, V. E. Bovbjerg et al., “Daily assessment of pain in adults with sickle cell disease,” Annals of Internal Medicine, vol. 148, no. 2, pp. 94–101, 2008. View at Google Scholar · View at Scopus
  401. J. N. Stinson, T. Kavanagh, J. Yamada, N. Gill, and B. Stevens, “Systematic review of the psychometric properties, interpretability and feasibility of self-report pain intensity measures for use in clinical trials in children and adolescents,” Pain, vol. 125, no. 1-2, pp. 143–157, 2006. View at Publisher · View at Google Scholar · View at Scopus
  402. P. J. McGrath, G. A. Walco, D. C. Turk et al., “Core outcome domains and measures for pediatric acute and chronic/recurrent pain clinical trials: PedIMMPACT recommendations,” The Journal of Pain, vol. 9, no. 9, pp. 771–783, 2008. View at Publisher · View at Google Scholar · View at Scopus
  403. C. L. von Baeyer and L. J. Spagrud, “Systematic review of observational (behavioral) measures of pain for children and adolescents aged 3 to 18 years,” Pain, vol. 127, no. 1-2, pp. 140–150, 2007. View at Publisher · View at Google Scholar · View at Scopus
  404. B. Ely, C. Dampier, M. Gilday, P. O'Neal, and D. Brodecki, “Caregiver report of pain in infants and toddlers with sickle cell disease: reliability and validity of a daily diary,” The Journal of Pain, vol. 3, no. 1, pp. 50–57, 2002. View at Publisher · View at Google Scholar · View at Scopus
  405. G. A. Walco and C. D. Dampier, “Pain in children and adolescents with sickle cell disease: a descriptive study,” Journal of Pediatric Psychology, vol. 15, no. 5, pp. 643–658, 1990. View at Google Scholar · View at Scopus
  406. E. Jacob and B. U. Mueller, “Pain experience of children with sickle cell disease who had prolonged hospitalizations for acute painful episodes,” Pain Medicine, vol. 9, no. 1, pp. 13–21, 2008. View at Publisher · View at Google Scholar · View at Scopus
  407. E. Jacob, C. Miaskowski, M. Savedra, J. E. Beyer, M. Treadwell, and L. Styles, “Changes in intensity, location, and quality of vaso-occlusive pain in children with sickle cell disease,” Pain, vol. 102, no. 1-2, pp. 187–193, 2003. View at Publisher · View at Google Scholar · View at Scopus
  408. S. E. Graumlich, S. W. Powers, K. C. Byars, L. A. Schwarber, M. J. Mitchell, and K. A. Kalinyak, “Multidimensional assessment of pain in pediatric sickle cell disease,” Journal of Pediatric Psychology, vol. 26, no. 4, pp. 203–214, 2001. View at Publisher · View at Google Scholar · View at Scopus
  409. K. M. Gil, J. W. Carson, L. S. Porter et al., “Daily stress and mood and their association with pain, health-care use, and school activity in adolescents with sickle cell disease,” Journal of Pediatric Psychology, vol. 28, no. 5, pp. 363–373, 2003. View at Publisher · View at Google Scholar · View at Scopus
  410. L. Pence, C. R. Valrie, K. M. Gil, R. Redding-Lallinger, and C. Daeschner, “Optimism predicting daily pain medication use in adolescents with sickle cell disease,” The Journal of Pain and Symptom Management, vol. 33, no. 3, pp. 302–309, 2007. View at Publisher · View at Google Scholar · View at Scopus
  411. K. Simon, L. P. Barakat, C. A. Patterson, and C. Dampier, “Symptoms of depression and anxiety in adolescents with sickle cell disease: the role of intrapersonal characteristics and stress processing variables,” Child Psychiatry and Human Development, vol. 40, no. 2, pp. 317–330, 2009. View at Publisher · View at Google Scholar · View at Scopus
  412. D. Amtmann, K. F. Cook, M. P. Jensen et al., “Development of a PROMIS item bank to measure pain interference,” Pain, vol. 150, no. 1, pp. 173–182, 2010. View at Publisher · View at Google Scholar · View at Scopus
  413. T. M. Palermo, D. Witherspoon, D. Valenzuela, and D. D. Drotar, “Development and validation of the Child Activity Limitations Interview: a measure of pain-related functional impairment in school-age children and adolescents,” Pain, vol. 109, no. 3, pp. 461–470, 2004. View at Publisher · View at Google Scholar · View at Scopus
  414. T. M. Palermo, A. S. Lewandowski, A. C. Long, and C. J. Burant, “Validation of a self-report questionnaire version of the Child Activity Limitations Interview (CALI): the CALI-21,” Pain, vol. 139, no. 3, pp. 644–652, 2008. View at Publisher · View at Google Scholar · View at Scopus
  415. A. C. Long, T. M. Palermo, and A. M. Manees, “Brief report: using actigraphy to compare physical activity levels in adolescents with chronic pain and healthy adolescents,” Journal of Pediatric Psychology, vol. 33, no. 6, pp. 660–665, 2008. View at Publisher · View at Google Scholar · View at Scopus
  416. C. Dampier, E. Ely, D. Brodecki, and P. O'Neal, “Home management of pain in sickle cell disease: a daily diary study in children and adolescents,” Journal of Pediatric Hematology/Oncology, vol. 24, no. 8, pp. 643–647, 2002. View at Publisher · View at Google Scholar · View at Scopus
  417. A. El-Tahtawy, H. Kokki, and B. E. Reidenberg, “Population pharmacokinetics of oxycodone in children 6 months to 7 years old,” Journal of Clinical Pharmacology, vol. 46, no. 4, pp. 433–442, 2006. View at Publisher · View at Google Scholar · View at Scopus
  418. C. Dampier, E. Ely, B. Eggleston, D. Brodecki, and P. O'Neal, “Physical and cognitive-behavioral activities used in the home management of sickle pain: a daily diary study in children and adolescents,” Pediatric Blood and Cancer, vol. 43, no. 6, pp. 674–678, 2004. View at Publisher · View at Google Scholar · View at Scopus
  419. L. P. Barakat, L. A. Schwartz, K. S. Salamon, and J. Radcliffe, “A family-based randomized controlled trial of pain intervention for adolescents with sickle cell disease,” Journal of Pediatric Hematology/Oncology, vol. 32, no. 7, pp. 540–547, 2010. View at Publisher · View at Google Scholar · View at Scopus
  420. S. L. Yoon and S. Black, “Comprehensive, integrative management of pain for patients with sickle-cell disease,” Journal of Alternative and Complementary Medicine, vol. 12, no. 10, pp. 995–1001, 2006. View at Publisher · View at Google Scholar · View at Scopus
  421. P. B. Bodhise, M. Dejoie, Z. Brandon, S. Simpkins, and S. K. Ballas, “Non-pharmacologic management of sickle cell pain,” Hematology, vol. 9, no. 3, pp. 235–237, 2004. View at Google Scholar · View at Scopus
  422. S. Beider and C. A. Moyer, “Randomized controlled trials of pediatric massage: a review,” Evidence-Based Complementary and Alternative Medicine, vol. 4, no. 1, pp. 23–34, 2007. View at Publisher · View at Google Scholar · View at Scopus
  423. J. L. Raphael, A. Kamdar, M. B. Beavers, D. H. Mahoney, and B. U. Mueller, “Treatment of uncomplicated vaso-occlusive crises in children with sickle cell disease in a day hospital,” Pediatric Blood and Cancer, vol. 51, no. 1, pp. 82–85, 2008. View at Publisher · View at Google Scholar · View at Scopus
  424. T. M. Palermo, C. Eccleston, A. S. Lewandowski, A. C. D. C. Williams, and S. Morley, “Randomized controlled trials of psychological therapies for management of chronic pain in children and adolescents: an updated meta-analytic review,” Pain, vol. 148, no. 3, pp. 387–397, 2010. View at Publisher · View at Google Scholar · View at Scopus
  425. T. M. Palermo, “Enhancing daily functioning with exposure and acceptance strategies: an important stride in the development of psychological therapies for pediatric chronic pain,” Pain, vol. 141, no. 3, pp. 189–190, 2009. View at Publisher · View at Google Scholar · View at Scopus
  426. S. K. Ballas and M. Lusardi, “Hospital readmission for adult acute sickle cell painful episodes: frequency, etiology, and prognostic significance,” American Journal of Hematology, vol. 79, no. 1, pp. 17–25, 2005. View at Publisher · View at Google Scholar · View at Scopus
  427. E. P. Vichinsky, L. D. Neumayr, A. N. Earles et al., “Causes and outcomes of the acute chest syndrome in sickle cell disease,” The New England Journal of Medicine, vol. 342, no. 25, pp. 1855–1865, 2000. View at Publisher · View at Google Scholar · View at Scopus
  428. D. S. Darbari, P. Kple-Faget, J. Kwagyan, S. Rana, V. R. Gordeuk, and O. Castro, “Circumstances of death in adult sickle cell disease patients,” American Journal of Hematology, vol. 81, no. 11, pp. 858–863, 2006. View at Publisher · View at Google Scholar · View at Scopus
  429. E. A. Manci, D. E. Culberson, Y. M. Yang et al., “Causes of death in sickle cell disease: an autopsy study,” British Journal of Haematology, vol. 123, no. 2, pp. 359–365, 2003. View at Publisher · View at Google Scholar · View at Scopus
  430. G. R. Serjeant, C. D. E. Ceulaer, R. Lethbridge, J. Morris, A. Singhal, and P. W. Thomas, “The painful crisis of homozygous sickle cell disease: clinical features,” British Journal of Haematology, vol. 87, no. 3, pp. 586–591, 1994. View at Google Scholar · View at Scopus
  431. E. P. Vichinsky, R. Johnson, and B. H. Lubin, “Multidisciplinary approach to pain management in sickle cell disease,” American Journal of Pediatric Hematology/Oncology, vol. 4, no. 3, pp. 328–333, 1982. View at Google Scholar · View at Scopus
  432. O. S. Platt, B. D. Thorington, D. J. Brambilla et al., “Pain in sickle cell disease—rates and risk factors,” The New England Journal of Medicine, vol. 325, no. 1, pp. 11–16, 1991. View at Google Scholar · View at Scopus
  433. R. B. Francis Jr. and C. S. Johnson, “Vascular occlusion in Sickle Cell disease: current concepts and unanswered questions,” Blood, vol. 77, no. 7, pp. 1405–1414, 1991. View at Google Scholar · View at Scopus
  434. D. R. Bonds, “Three decades of innovation in the management of sickle cell disease: the road to understanding the sickle cell disease clinical phenotype,” Blood Reviews, vol. 19, no. 2, pp. 99–110, 2005. View at Publisher · View at Google Scholar · View at Scopus
  435. M. H. Steinberg, “Predicting clinical severity in sickle cell anaemia,” British Journal of Haematology, vol. 129, no. 4, pp. 465–481, 2005. View at Publisher · View at Google Scholar · View at Scopus
  436. D. R. Powars, “Sickle cell anemia: β(S)-gene-cluster haplotypes as prognostic indicators of vital organ failure,” Seminars in Hematology, vol. 28, no. 3, pp. 202–208, 1991. View at Google Scholar · View at Scopus
  437. E. Udezue and A. M. Girshab, “Differences between males and females in adult sickle cell pain crisis in eastern Saudi Arabia,” Annals of Saudi Medicine, vol. 24, no. 3, pp. 179–182, 2004. View at Google Scholar · View at Scopus
  438. S. K. Ballas, J. Larner, E. D. Smith, S. Surrey, E. Schwartz, and E. F. Rappaport, “Rheologic predictors of the severity of the painful sickle cell crisis,” Blood, vol. 72, no. 4, pp. 1216–1223, 1988. View at Google Scholar · View at Scopus
  439. W. M. Lande, D. L. Andrews, M. R. Clark et al., “The incidence of painful crisis in homozygous sickle cell disease: correlation with red cell deformability,” Blood, vol. 72, no. 6, pp. 2056–2059, 1988. View at Google Scholar · View at Scopus
  440. K. F. Baum, D. T. Dunn, G. H. Maude, and G. R. Serjeant, “The painful crisis of homozygous sickle cell disease. A study of risk factors,” Archives of Internal Medicine, vol. 147, no. 7, pp. 1231–1234, 1987. View at Google Scholar · View at Scopus
  441. D. R. Hargrave, A. Wade, J. P. M. Evans, D. K. M. Hewes, and F. J. Kirkham, “Nocturnal oxygen saturation and painful sickle cell crises in children,” Blood, vol. 101, no. 3, pp. 846–848, 2003. View at Publisher · View at Google Scholar · View at Scopus
  442. J. I. Schall, B. S. Zemel, D. A. Kawchak, K. Ohene-Frempong, and V. A. Stallings, “Vitamin A status, hospitalizations, and other outcomes in young children with sickle cell disease,” Journal of Pediatrics, vol. 145, no. 1, pp. 99–106, 2004. View at Publisher · View at Google Scholar · View at Scopus
  443. S. K. Ballas, Sickle Cell Pain. Progress in Pain Research and Management, vol. 11, IASP Press, Seattle, Wash, USA, 1998.
  444. L. J. Benjamin, “Nature and treatment of the acute painful episode in sickle cell disease,” in Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management, M. H. Steinberg et al., Ed., pp. 671–710, Cambridge University Press, New York, NY, USA, 2001. View at Google Scholar
  445. K. M. Gil, J. W. Carson, L. S. Porter, C. Scipio, S. M. Bediako, and E. Orringer, “Daily mood and stress predict pain, health care use, and work activity in African American adults with sickle-cell disease,” Health Psychology, vol. 23, no. 3, pp. 267–274, 2004. View at Publisher · View at Google Scholar · View at Scopus
  446. H. Amjad, R. M. Bannerman, and J. M. Judisch, “Letter: sickling pain and season,” British Medical Journal, vol. 2, no. 5909, p. 54, 1974. View at Google Scholar · View at Scopus
  447. A. S. Ibrahim, “Relationship between meteorological changes and occurrence of painful sickle cell crises in Kuwait,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 74, no. 2, pp. 159–161, 1980. View at Google Scholar · View at Scopus
  448. A. M. Redwood, E. M. Williams, P. Desai, and G. R. Serjeant, “Climate and painful crisis of sickle cell disease in Jamaica,” British Medical Journal, vol. 1, no. 6001, pp. 66–68, 1976. View at Google Scholar · View at Scopus
  449. M. O. Kehinde, J. C. W. Marsh, and G. W. Marsh, “Sickle cell disease in North London,” British Journal of Haematology, vol. 66, no. 4, pp. 543–547, 1987. View at Google Scholar · View at Scopus
  450. R. A. Seeler, “Non-seasonality of sickle-cell crisis,” The Lancet, vol. 2, no. 7831, p. 743, 1973. View at Google Scholar · View at Scopus
  451. C. M. Slovis, J. D. Talley, and R. B. Pitts, “Non relationship of climatologic factors and painful sickle cell anemia crisis,” Journal of Chronic Diseases, vol. 39, no. 2, pp. 121–126, 1986. View at Google Scholar · View at Scopus
  452. W. R. Smith, P. Coyne, V. S. Smith, and B. Mercier, “Temperature changes, temperature extremes, and their relationship to emergency department visits and hospitalizations for sickle cell crisis,” Pain Management Nursing, vol. 4, no. 3, pp. 106–111, 2003. View at Publisher · View at Google Scholar · View at Scopus
  453. S. Jones, E. R. Duncan, N. Thomas et al., “Windy weather and low humidity are associated with an increased number of hospital admissions for acute pain and sickle cell disease in an urban environment with a maritime temperate climate,” British Journal of Haematology, vol. 131, no. 4, pp. 530–533, 2005. View at Publisher · View at Google Scholar · View at Scopus
  454. D. Yallop, E. R. Duncan, E. Norris et al., “The associations between air quality and the number of hospital admissions for acute pain and sickle-cell disease in an urban environment,” British Journal of Haematology, vol. 136, no. 6, pp. 844–848, 2007. View at Publisher · View at Google Scholar · View at Scopus
  455. L. M. S. Resar and F. A. Oski, “Cold water exposure and vaso-occlusive crises in sickle cell anemia,” Journal of Pediatrics, vol. 118, no. 3, pp. 407–409, 1991. View at Google Scholar · View at Scopus
  456. S. K. Ballas and A. Delengowski, “Pain measurement in hospitalized adults with sickle cell painful episodes,” Annals of Clinical and Laboratory Science, vol. 23, no. 5, pp. 358–361, 1993. View at Google Scholar · View at Scopus
  457. S. B. Mcmahon and M. Koltzenburg, Eds., Wall and Melzack's Textbook of Pain, Elsevier, New York, NY, USA, 5th edition, 2006.
  458. S. M. Fishman, J. C. Balantyne, and J. P. Rathmell, Eds., Bonica's Management of Pain, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 2010.
  459. P. H. Coluzzi, L. Schwartzberg, J. D. Conroy et al., “Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR),” Pain, vol. 91, no. 1-2, pp. 123–130, 2001. View at Publisher · View at Google Scholar · View at Scopus
  460. L. J. Benjamin et al., Guideline for the Management of Acute and Chronic Pain in Sickle-Cell Disease, American Pain Society, Genview, 1999.
  461. L. J. Benjamin, “Nature and treatmentof the acute painful episode in sickle cell disease,” in Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management, M. H. Steinberg, B. G. Forget, D. R. Higgs, and R. L. Nagel, Eds., pp. 671–710, Cambridge University Press, Cambridge, UK, 2001. View at Google Scholar
  462. C. S. Cleeland, “Strategies for improving cancer pain management,” The Journal of Pain and Symptom Management, vol. 8, no. 6, pp. 361–364, 1993. View at Publisher · View at Google Scholar · View at Scopus
  463. W. T. Beaver, “Impact of non-narcoti oral analgesics on pain management,” American Journal of Medicine, vol. 84, no. 5, pp. 3–15, 1988. View at Google Scholar · View at Scopus
  464. M. F. Ferrante, “Opioids,” in Postoperative Pain Management, F. M. Ferrante and T. R. Vedeboncouer, Eds., pp. 145–209, Churchill Livingstone, New York, NY, USA, 1993. View at Google Scholar
  465. M. J. Krantz, I. B. Kutinsky, A. D. Robertson, and P. S. Mehler, “Dose-related effects of methadone on QT prolongation in a series of patients with torsade de pointes,” Pharmacotherapy, vol. 23, no. 6, pp. 802–805, 2003. View at Publisher · View at Google Scholar · View at Scopus
  466. S. H. Zyoud, R. Awang, and S. A. S. Sulaiman, “Reliability of the reported ingested dose of acetaminophen for predicting the risk of toxicity in acetaminophen overdose patients,” Pharmacoepidemiology and Drug Safety, vol. 21, no. 2, pp. 207–213, 2011. View at Publisher · View at Google Scholar · View at Scopus
  467. R. Chou, G. J. Fanciullo, P. G. Fine et al., “Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain,” The Journal of Pain, vol. 10, no. 2, pp. 113–130, 2009. View at Google Scholar
  468. R. Chou, G. J. Fanciullo, P. G. Fine, C. Miaskowski, S. D. Passik, and R. K. Portenoy, “Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline,” The Journal of Pain, vol. 10, no. 2, pp. 131–146, 2009. View at Publisher · View at Google Scholar · View at Scopus
  469. World health Organization, “Cancer pain Relief and Palliative care,” World Health Organization Technical Report Series no. 804, World Health Organization, Geneva, Switzerland, 1990.
  470. C. Kolb, “Playing with pain killers,” Newsweek, pp. 45–51, 2001.
  471. M. H. Gaston, J. I. Verter, and G. Woods, “Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial,” The New England Journal of Medicine, vol. 314, no. 25, pp. 1593–1599, 1986. View at Google Scholar · View at Scopus
  472. M. H. Steinberg, “Hydroxyurea treatment for sickle cell disease,” The Scientific World Journal, vol. 2, pp. 1706–1728, 2002. View at Google Scholar · View at Scopus
  473. S. Charache, M. L. Terrin, R. D. Moore et al., “Effect of hydroxyurea on the frequency of painful crises in Sickle cell anemia,” The New England Journal of Medicine, vol. 332, no. 20, pp. 1317–1322, 1995. View at Publisher · View at Google Scholar · View at Scopus
  474. S. Charache, F. B. Barton, R. D. Moore et al., “Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive “switching” agent,” Medicine, vol. 75, no. 6, pp. 300–326, 1996. View at Google Scholar · View at Scopus
  475. W. C. Wang, R. E. Ware, S. T. Miller et al., “Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG),” The Lancet, vol. 377, no. 9778, pp. 1663–1672, 2011. View at Publisher · View at Google Scholar · View at Scopus
  476. M. H. Steinberg, “Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment,” JAMA: The Journal of the American Medical Association, vol. 289, no. 13, pp. 1645–1651, 2003. View at Google Scholar
  477. S. Charache, J. C. Scott, and P. Charache, ““Acute chest syndrome” in adults with sickle cell anemia. Microbiology, treatment, and prevention,” Archives of Internal Medicine, vol. 139, no. 1, pp. 67–69, 1979. View at Publisher · View at Google Scholar · View at Scopus
  478. O. Castro, D. J. Brambilla, B. Thorington et al., “The acute chest syndrome in sickle cell disease: incidence and risk factors,” Blood, vol. 84, no. 2, pp. 643–649, 1994. View at Google Scholar · View at Scopus
  479. E. P. Vichinsky, L. A. Styles, L. H. Colangelo, E. C. Wright, O. Castro, and B. Nickerson, “Acute chest syndrome in sickle cell disease: clinical presentation and course,” Blood, vol. 89, no. 5, pp. 1787–1792, 1997. View at Google Scholar · View at Scopus
  480. E. P. Vichinsky, L. D. Neumayr, A. N. Earles et al., “Causes and outcomes of the acute chest syndrome in sickle cell disease,” The New England Journal of Medicine, vol. 342, no. 25, pp. 1855–1865, 2000. View at Publisher · View at Google Scholar · View at Scopus
  481. L. A. Styles, C. G. Schalkwijk, A. J. Aarsman, E. P. Vichinsky, B. H. Lubin, and F. A. Kuypers, “Phospholipase A2 levels in acute chest syndrome of sickle cell disease,” Blood, vol. 87, no. 6, pp. 2573–2578, 1996. View at Google Scholar · View at Scopus
  482. A. N. Thomas, C. Pattison, and G. R. Serjeant, “Causes of death in sickle-cell disease in Jamaica,” British Medical Journal, vol. 285, no. 6342, pp. 633–635, 1982. View at Google Scholar · View at Scopus
  483. E. P. Vichinsky, “Comprehensive care in sickle cell disease: its impact on morbidity and mortality,” Seminars in Hematology, vol. 28, no. 3, pp. 220–226, 1991. View at Google Scholar · View at Scopus
  484. M. A. van Agtmael, J. D. Cheng, and H. C. Nossent, “Acute chest syndrome in adult Afro-Caribbean patients with sickle cell disease: analysis of 81 episodes among 53 patients,” Archives of Internal Medicine, vol. 154, no. 5, pp. 557–561, 1994. View at Publisher · View at Google Scholar · View at Scopus
  485. F. M. Gill, L. A. Sleeper, S. J. Weiner et al., “Clinical events in the first decade in a cohort of infants with sickle cell disease,” Blood, vol. 86, no. 2, pp. 776–783, 1995. View at Google Scholar · View at Scopus
  486. S. K. Ballas and C. H. Park, “Severe hypoxemia secondary to acute sternal infarction in sickle cell anemia,” Journal of Nuclear Medicine, vol. 32, no. 8, pp. 1617–1618, 1991. View at Google Scholar · View at Scopus
  487. D. L. Rucknagel, K. A. Kalinyak, and M. J. Gelfand, “Rib infarcts and acute chest syndrome in sickle cell diseases,” The Lancet, vol. 337, no. 8745, pp. 831–833, 1991. View at Publisher · View at Google Scholar · View at Scopus
  488. P. S. Bellet, K. A. Kalinyak, R. Shukla, M. J. Gelfand, and D. L. Rucknagel, “Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases,” The New England Journal of Medicine, vol. 333, no. 11, pp. 699–703, 1995. View at Publisher · View at Google Scholar · View at Scopus
  489. P. D. Stein, A. Beemath, F. A. Meyers, E. Skaf, and R. E. Olson, “Deep venous thrombosis and pulmonary embolism in hospitalized patients with sickle cell disease,” American Journal of Medicine, vol. 119, no. 10, pp. 897-e7–897-e11, 2006. View at Publisher · View at Google Scholar · View at Scopus
  490. M. R. Abboud, E. C. Taylor, D. Habib et al., “Elevated serum and bronchoalveolar lavage fluid levels of interleukin 8 and granulocyte colony-stimulating factor associated with the acute chest syndrome in patients with sickle cell disease,” British Journal of Haematology, vol. 111, no. 2, pp. 482–490, 2000. View at Publisher · View at Google Scholar · View at Scopus
  491. D. Alhashimi, Z. Fedorowicz, F. Alhashimi, and S. Dastgiri, “Blood transfusions for treating acute chest syndrome in people with sickle cell disease,” Cochrane Database of Systematic Reviews (Online), no. 1, Article ID CD007843, 2010. View at Google Scholar · View at Scopus
  492. J. C. Bernini, Z. R. Rogers, E. S. Sandler, J. S. Reisch, C. T. Quinn, and G. R. Buchanan, “Beneficial effect of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease,” Blood, vol. 92, no. 9, pp. 3082–3089, 1998. View at Google Scholar · View at Scopus
  493. J. C. Huang, R. Gay, and S. L. Khella, “Sickling crisis, fat embolism, and coma after steroids,” The Lancet, vol. 344, no. 8927, pp. 951–952, 1994. View at Publisher · View at Google Scholar · View at Scopus
  494. D. S. Darbari, O. Castro, J. G. Taylor et al., “Severe vaso-occlusive episodes associated with use of systemic corticosteroids in patients with sickle cell disease,” Journal of the National Medical Association, vol. 100, no. 8, pp. 948–951, 2008. View at Google Scholar · View at Scopus
  495. S. K. Ballas, “Corticosteroids and sickle cell disease,” Journal of the National Medical Association, vol. 101, no. 3, p. 283, 2009. View at Google Scholar · View at Scopus
  496. A. M. Atz and D. L. Wessel, “Inhaled nitric oxide in sickle cell disease with acute chest syndrome,” Anesthesiology, vol. 87, no. 4, pp. 988–990, 1997. View at Publisher · View at Google Scholar · View at Scopus
  497. S. K. Ballas, B. Files, L. Luchtman-Jones et al., “Safety of purified poloxamer 188 in sickle cell disease: phase I study of a non-ionic surfactant in the management of acute chest syndrome,” Hemoglobin, vol. 28, no. 2, pp. 85–102, 2004. View at Publisher · View at Google Scholar · View at Scopus
  498. P. Adams-Graves, A. Kedar, M. Koshy et al., “RheothRx (Poloxamer 188) injection for the acute painful episode of sickle cell disease: a pilot study,” Blood, vol. 90, no. 5, pp. 2041–2046, 1997. View at Google Scholar · View at Scopus
  499. D. L. Weiner, P. L. Hibberd, P. Betit, A. B. Cooper, C. A. Botelho, and C. Brugnara, “Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease,” Journal of the American Medical Association, vol. 289, no. 9, pp. 1136–1142, 2003. View at Publisher · View at Google Scholar · View at Scopus
  500. T. Ikuta, H. S. Thatte, J. X. Tang et al., “Nitric oxide reduces sickle hemoglobin polymerization: potential role of nitric oxide-induced charge alteration in depolymerization,” Archives of Biochemistry and Biophysics, vol. 510, no. 1, pp. 53–61, 2011. View at Publisher · View at Google Scholar · View at Scopus
  501. C. A. Head, P. Swerdlow, W. A. McDade et al., “Beneficial effects of nitric oxide breathing in adult patients with sickle cell crisis,” American Journal of Hematology, vol. 85, no. 10, pp. 800–802, 2010. View at Publisher · View at Google Scholar · View at Scopus
  502. M. T. Gladwin, G. J. Kato, D. Weiner et al., “Nitric oxide for inhalation in the acute treatment of sickle cell pain crisis: a randomized controlled trial,” JAMA: Journal of the American Medical Association, vol. 305, no. 9, pp. 893–902, 2011. View at Publisher · View at Google Scholar · View at Scopus
  503. O. Castro, M. Hoque, and B. D. Brown, “Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival,” Blood, vol. 101, no. 4, pp. 1257–1261, 2003. View at Publisher · View at Google Scholar · View at Scopus
  504. M. T. Gladwin, V. Sachdev, M. L. Jison et al., “Pulmonary hypertension as a risk factor for death in patients with sickle cell disease,” The New England Journal of Medicine, vol. 350, no. 9, pp. 886–895, 2004. View at Publisher · View at Google Scholar · View at Scopus
  505. G. H. Fonseca, R. Souza, V. M. Salemi, C. V. Jardim, and S. F. Gualandro, “Pulmonary hypertension diagnosed by right heart catheterization in sickle cell disease,” European Respiratory Journal, vol. 39, no. 1, pp. 112–118, 2012. View at Google Scholar
  506. F. Parent, D. Bachir, J. Inamo et al., “A hemodynamic study of pulmonary hypertension in sickle cell disease,” The New England Journal of Medicine, vol. 365, no. 1, pp. 44–53, 2011. View at Google Scholar
  507. H. F. Bunn, D. G. Nathan, G. J. Dover et al., “Pulmonary hypertension and nitric oxide depletion in sickle cell disease,” Blood, vol. 116, no. 5, pp. 687–692, 2010. View at Publisher · View at Google Scholar · View at Scopus
  508. R. P. Hebbel, “Reconstructing sickle cell disease: a data-based analysis of the "hyperhemolysis paradigm" for pulmonary hypertension from the perspective of evidence-based medicine,” American Journal of Hematology, vol. 86, no. 2, pp. 123–154, 2011. View at Publisher · View at Google Scholar · View at Scopus
  509. J. E. Knight-Perry, L. de Las Fuentes, A. D. Waggoner et al., “Abnormalities in cardiac structure and function in adults with sickle cell disease are not associated with pulmonary hypertension,” Journal of the American Society of Echocardiography, vol. 24, no. 11, pp. 1285–1290, 2011. View at Google Scholar
  510. M. C. Johnson, F. J. Kirkham, S. Redline et al., “Left ventricular hypertrophy and diastolic dysfunction in children with sickle cell disease are related to asleep and waking oxygen desaturation,” Blood, vol. 116, no. 1, pp. 16–21, 2010. View at Publisher · View at Google Scholar · View at Scopus
  511. F. D. Pashankar, J. Carbonella, A. Bazzy-Asaad, and A. Friedman, “Longitudinal follow up of elevated pulmonary artery pressures in children with sickle cell disease,” British Journal of Haematology, vol. 144, no. 5, pp. 736–741, 2009. View at Publisher · View at Google Scholar · View at Scopus
  512. S. Forrest, A. Kim, J. Carbonella, and F. Pashankar, “Proteinuria is associated with elevated tricuspid regurgitant jet velocity in children with sickle cell disease,” Pediatric Blood and Cancer, vol. 58, no. 6, pp. 937–940, 2012. View at Publisher · View at Google Scholar
  513. C. P. Minniti, C. Sable, A. Campbell et al., “Elevated tricuspid regurgitant jet velocity in children and adolescents with sickle cell disease: association with hemolysis and hemoglobin oxygen desaturation,” Haematologica, vol. 94, no. 3, pp. 340–347, 2009. View at Publisher · View at Google Scholar · View at Scopus
  514. V. Sachdev, G. J. Kato, J. S. R. Gibbs et al., “Echocardiographic markers of elevated pulmonary pressure and left ventricular diastolic dysfunction are associated with exercise intolerance in adults and adolescents with homozygous sickle cell anemia in the United States and United Kingdom,” Circulation, vol. 124, no. 13, pp. 1452–1460, 2011. View at Google Scholar
  515. R. F. Machado, M. Hildesheim, L. Mendelsohn, A. T. Remaley, G. J. Kato, and M. T. Gladwin, “NT-pro brain natriuretic peptide levels and the risk of death in the cooperative study of sickle cell disease,” British Journal of Haematology, vol. 154, no. 4, pp. 512–520, 2011. View at Publisher · View at Google Scholar · View at Scopus
  516. R. F. Machado and M. T. Gladwin, “Pulmonary hypertension in hemolytic disorders: pulmonary vascular disease: the global perspective,” Chest, vol. 137, no. 6, supplement, pp. 30S–38S, 2010. View at Publisher · View at Google Scholar · View at Scopus
  517. K. C. Wood, L. L. Hsu, and M. T. Gladwin, “Sickle cell disease vasculopathy: a state of nitric oxide resistance,” Free Radical Biology and Medicine, vol. 44, no. 8, pp. 1506–1528, 2008. View at Publisher · View at Google Scholar · View at Scopus
  518. C. R. Morris, G. J. Kato, M. Poljakovic et al., “Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease,” Journal of the American Medical Association, vol. 294, no. 1, pp. 81–90, 2005. View at Publisher · View at Google Scholar · View at Scopus
  519. M. L. Jison and M. T. Gladwin, “Hemolytic anemia-associated pulmonary hypertension of sickle cell disease and the nitric oxide/arginine pathway,” American Journal of Respiratory and Critical Care Medicine, vol. 168, no. 1, pp. 3–4, 2003. View at Publisher · View at Google Scholar · View at Scopus
  520. G. J. Kato and J. G. Taylor, “Pleiotropic effects of intravascular haemolysis on vascular homeostasis,” British Journal of Haematology, vol. 148, no. 5, pp. 690–701, 2010. View at Publisher · View at Google Scholar · View at Scopus
  521. K. I. Ataga, C. G. Moore, C. A. Hillery et al., “Coagulation activation and inflammation in sickle cell disease-associated pulmonary hypertension,” Haematologica, vol. 93, no. 1, pp. 20–26, 2008. View at Publisher · View at Google Scholar · View at Scopus
  522. G. J. Kato, S. Martyr, W. C. Blackwelder et al., “Levels of soluble endothelium-derived adhesion molecules in patients with sickle cell disease are associated with pulmonary hypertension, organ dysfunction, and mortality,” British Journal of Haematology, vol. 130, no. 6, pp. 943–953, 2005. View at Publisher · View at Google Scholar · View at Scopus
  523. E. S. Klings, “Pulmonary hypertension of sickle cell disease: more than just another lung disease,” American Journal of Hematology, vol. 83, no. 1, pp. 4–5, 2008. View at Publisher · View at Google Scholar · View at Scopus
  524. E. S. Klings, D. A. Bland, D. Rosenman et al., “Pulmonary arterial hypertension and left-sided heart disease in sickle cell disease: clinical characteristics and association with soluble adhesion molecule expression,” American Journal of Hematology, vol. 83, no. 7, pp. 547–553, 2008. View at Publisher · View at Google Scholar · View at Scopus
  525. A. Anthi, R. F. Machado, M. L. Jison et al., “Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertension,” American Journal of Respiratory and Critical Care Medicine, vol. 175, no. 12, pp. 1272–1279, 2007. View at Publisher · View at Google Scholar
  526. R. J. Barst, K. K. Mubarak, R. F. MacHado et al., “Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies,” British Journal of Haematology, vol. 149, no. 3, pp. 426–435, 2010. View at Publisher · View at Google Scholar · View at Scopus
  527. C. S. P. Lima, O. M. Ueti, A. A. Ueti, K. G. Franchini, F. F. Costa, and S. T. O. Saad, “Enalapril therapy and cardiac remodelling in sickle cell disease patients,” Acta Cardiologica, vol. 63, no. 5, pp. 599–602, 2008. View at Publisher · View at Google Scholar · View at Scopus
  528. D. S. Darbari, P. Kple-Faget, J. Kwagyan, S. Rana, V. R. Gordeuk, and O. Castro, “Circumstances of death in adult sickle cell disease patients,” American Journal of Hematology, vol. 81, no. 11, pp. 858–863, 2006. View at Publisher · View at Google Scholar · View at Scopus
  529. A. El-Beshlawy, E. Abd El Raouf, F. Mostafa et al., “Diastolic dysfunction and pulmonary hypertension in sickle cell anemia: is there a role for L-carnitine treatment?” Acta Haematologica, vol. 115, no. 1-2, pp. 91–96, 2006. View at Publisher · View at Google Scholar · View at Scopus
  530. S. V. Raman, O. P. Simonetti, S. R. Cataland, and E. H. Kraut, “Myocardial ischemia and right ventricular dysfunction in adult patients with sickle cell disease,” Haematologica, vol. 91, no. 10, pp. 1329–1335, 2006. View at Google Scholar · View at Scopus
  531. C.R. Morris, G. Kato, M. Poljakov et al., “The arginine-to-ornithine ratio: biomarker of arginase activity and predictor of mortality in sickle cell disease,” Blood, vol. 104, no. 1, article 71a, 2004. View at Google Scholar
  532. K. V. Morris, “siRNA-mediated transcriptional gene silencing: the potential mechanism and a possible role in the histone code,” Cellular and Molecular Life Sciences, vol. 62, no. 24, pp. 3057–3066, 2005. View at Publisher · View at Google Scholar · View at Scopus
  533. B. L. Lopez, A. A. Kreshak, C. R. Morris, L. Davis-Moon, S. K. Ballas, and X. L. Ma, “L-arginine levels are diminished in adult acute vaso-occlusive sickle cell crisis in the emergency department,” British Journal of Haematology, vol. 120, no. 3, pp. 532–534, 2003. View at Publisher · View at Google Scholar · View at Scopus
  534. N. Patel, C. S. Gonsalves, P. Malik, and V. K. Kalra, “Placenta growth factor augments endothelin-1 and endothelin-B receptor expression via hypoxia-inducible factor-1α,” Blood, vol. 112, no. 3, pp. 856–865, 2008. View at Publisher · View at Google Scholar · View at Scopus
  535. N. Patel, N. Sundaram, M. Yang, C. Madigan, V. K. Kalra, and P. Malik, “Placenta Growth Factor (PlGF), a novel inducer of Plasminogen Activator Inhibitor-1 (PAI-1) in Sickle Cell Disease (SCD),” The Journal of Biological Chemistry, vol. 285, no. 22, pp. 16713–16722, 2010. View at Publisher · View at Google Scholar · View at Scopus
  536. N. Sundaram, A. Tailor, L. Mendelsohn et al., “High levels of placenta growth factor in sickle cell disease promote pulmonary hypertension,” Blood, vol. 116, no. 1, pp. 109–112, 2010. View at Google Scholar
  537. J. E. Brittain, B. Hulkower, S. K. Jones et al., “Placenta growth factor in sickle cell disease: association with hemolysis and inflammation,” Blood, vol. 115, no. 10, pp. 2014–2020, 2010. View at Publisher · View at Google Scholar · View at Scopus
  538. K. I. Ataga, J. E. Brittain, D. Moore et al., “Urinary albumin excretion is associated with pulmonary hypertension in sickle cell disease: potential role of soluble fms-like tyrosine kinase-1,” European Journal of Haematology, vol. 85, no. 3, pp. 257–263, 2010. View at Publisher · View at Google Scholar · View at Scopus
  539. C. P. Minniti, R. F. MacHado, W. A. Coles, V. Sachdev, M. T. Gladwin, and G. J. Kato, “Endothelin receptor antagonists for pulmonary hypertension in adult patients with sickle cell disease,” British Journal of Haematology, vol. 147, no. 5, pp. 737–743, 2009. View at Publisher · View at Google Scholar · View at Scopus
  540. N. Sabaa, L. De Franceschi, P. Bonnin et al., “Endothelin receptor antagonism prevents hypoxia-induced mortality and morbidity in a mouse model of sickle-cell disease,” Journal of Clinical Investigation, vol. 118, no. 5, pp. 1924–1933, 2008. View at Publisher · View at Google Scholar · View at Scopus
  541. R. F. Machado, R. J. Barst, N. A. Yovetich et al., “Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity,” Blood, vol. 118, no. 4, pp. 855–864, 2011. View at Publisher · View at Google Scholar · View at Scopus
  542. O. Castro and M.T. Gladwin, “Pulmonary hypertension in sickle cell disease: mechanisms, diagnosis, and management,” Hematology/Oncology Clinics of North America, vol. 19, no. 5, pp. 881–896, 2005. View at Google Scholar
  543. L.L. Sutton, O. Castro, D.J. Cross, J.E. Spencer, and J.F. Lewis, “Pulmonary hypertension in sickle cell disease,” American Journal of Cardiology, vol. 74, no. 6, pp. 626–628, 1994. View at Google Scholar
  544. P. T. T. Pham, P. C. T. Pham, A. H. Wilkinson, and S. Q. Lew, “Renal abnormalities in sickle cell disease,” Kidney International, vol. 57, no. 1, pp. 1–8, 2000. View at Publisher · View at Google Scholar · View at Scopus
  545. L. D. S. Feltran, J. T. D. A. Carvalhaes, and R. Sesso, “Renal complications of sickle cell disease: managing for optimal outcomes,” Pediatric Drugs, vol. 4, no. 1, pp. 29–36, 2002. View at Google Scholar · View at Scopus
  546. R. J. Falk, J. Scheinman, G. Phillips, E. Orringer, A. Johnson, and J. C. Jennette, “Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme,” The New England Journal of Medicine, vol. 326, no. 14, pp. 910–915, 1992. View at Google Scholar · View at Scopus
  547. D. R. Powars, D. D. Elliott-Mills, L. Chan et al., “Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality,” Annals of Internal Medicine, vol. 115, no. 8, pp. 614–620, 1991. View at Google Scholar · View at Scopus
  548. A. L. Hiti, L. Zeng, Q. Xiang, F. W. Lorey, and D. R. Powars, “Beta-globin haplotypes from blood spots for follow-up of newborn hemoglobinopathy screening,” American Journal of Hematology, vol. 54, no. 1, pp. 76–78, 1997. View at Google Scholar
  549. A. A. Bakir, S. C. Hathiwala, H. Ainis et al., “Prognosis of the nephrotic syndrome in sickle glomerulopathy. A retrospective study,” American Journal of Nephrology, vol. 7, no. 2, pp. 110–115, 1987. View at Google Scholar · View at Scopus
  550. K. I. Ataga and E. P. Orringer, “Renal abnormalities in sickle cell disease,” American Journal of Hematology, vol. 63, no. 4, pp. 205–211, 2000. View at Google Scholar
  551. D.E. Wesson, “The initiation and progression of sickle cell nephropathy,” Kidney International, vol. 61, no. 6, pp. 2277–2286, 2002. View at Google Scholar
  552. P. E. de Jong, A. W. Saleh, D. de Zeeuw et al., “Urinary prostaglandins in sickle cell nephropathy: a defect in 9-ketoreductase activity?” Clinical Nephrology, vol. 22, no. 4, pp. 212–213, 1984. View at Google Scholar · View at Scopus
  553. N. Bank, H. S. Aynedjian, J. H. Qiu et al., “Renal nitric oxide synthase in transgenic sickle cell mice,” Kidney International, vol. 50, no. 1, pp. 184–189, 1996. View at Google Scholar · View at Scopus
  554. H. A. Itano, H. G. Keitel, and D. Thompson, “Hyposthenuria in sickle cell anemia: a reversible renal defect,” The Journal of Clinical Investigation, vol. 35, no. 9, pp. 998–1007, 1956. View at Google Scholar · View at Scopus
  555. L. W. S. van Eps, H. Schouten, L. W. La Porte-Wijsman, and A. M. Struyker Boudier, “The influence of red blood cell transfusions on the hyposthenuria and renal hemodynamics of sickle cell anemia,” Clinica Chimica Acta, vol. 17, no. 3, pp. 449–461, 1967. View at Google Scholar · View at Scopus
  556. J.I. Scheinman, “Sickle cell disease and the kidney,” Nature Clinical Practice Nephrology, vol. 5, no. 2, pp. 78–88, 2009. View at Google Scholar
  557. H. W. Kunz, E. L. Pratt, G. W. Mellin, and M. W. Cheung, “Impairment of urinary concentration in sickle cell anemia,” Pediatrics, vol. 13, no. 4, pp. 352–356, 1954. View at Google Scholar · View at Scopus
  558. Y. F. Francis and H. G. Worthen, “Hyposthenuria in sickle cell disease,” Journal of the National Medical Association, vol. 60, no. 4, pp. 266–270, 1968. View at Google Scholar · View at Scopus
  559. L. W. Statius Van Eps, H. Schouten, C. C. Ter Haar Romeny-Wachter, and L. W. La Porte-Wijsman, “The relation between age and renal concentrating capacity in sickle cell disease and hemoglobin C disease,” Clinica Chimica Acta, vol. 27, no. 3, pp. 501–511, 1970. View at Google Scholar · View at Scopus
  560. A. K. Gupta, K. A. Kirchner, R. Nicholson et al., “Effects of α-thalassemia and sickle polymerization tendency on the urine-concentrating defect of individuals with sickle cell trait,” Journal of Clinical Investigation, vol. 88, no. 6, pp. 1963–1968, 1991. View at Google Scholar · View at Scopus
  561. R. Iyer, R. Baliga, and R. L. Nagel, “Maximum urine concentrating ability in children with Hb SC disease: effects of hydroxyurea,” American Journal of Hematology, vol. 64, no. 1, pp. 47–52, 2000. View at Google Scholar
  562. R. E. Ware, R. C. Rees, and S. A. Sarnaik, “Renal function in infants with sickle cell anemia: baseline data from the BABY HUG trial,” Journal of Pediatrics, vol. 156, no. 1, article e61, pp. 66–70, 2010. View at Google Scholar
  563. R. A. DeFronzo, P. A. Taufield, H. Black, P. McPhedran, and C. R. Cooke, “Impaired renal tubular potassium secretion in sickle cell disease,” Annals of Internal Medicine, vol. 90, no. 3, pp. 310–316, 1979. View at Google Scholar · View at Scopus
  564. J. P. Goossens, L. W. S. Van Eps, H. Schouten, and A. L. Giterson, “Incomplete renal tubular acidosis in sickle cell disease,” Clinica Chimica Acta, vol. 41, pp. 149–156, 1972. View at Google Scholar · View at Scopus
  565. H. H. Kong and G. A. Alleyne, “Studies on acid excretion in adults with sickle-cell anaemia,” Clinical Science, vol. 41, no. 6, pp. 505–518, 1971. View at Google Scholar · View at Scopus
  566. D. Batle, M. Grupp, M. Gaviria, and N. A. Kurtzman, “Distal renal tubular acidosis with intact capacity to lower urinary pH,” American Journal of Medicine, vol. 72, no. 5, pp. 751–758, 1982. View at Google Scholar · View at Scopus
  567. J. R. Oster, L. E. Lespier, S. M. Lee, E. L. Pellegrini, and C. A. Vaamonde, “Renal acidification in sickle-cell disease,” Journal of Laboratory and Clinical Medicine, vol. 88, no. 3, pp. 389–401, 1976. View at Google Scholar
  568. J. R. Oster, S. M. Lee, L. E. Lespier, E. L. Pellegrini, and C. A. Vaamonde, “Renal acidification in sickle cell trait,” Archives of Internal Medicine, vol. 136, no. 1, pp. 30–35, 1976. View at Publisher · View at Google Scholar · View at Scopus
  569. O. Alvarez, B. Montane, G. Lopez, J. Wilkinson, and T. Miller, “Early blood transfusions protect against microalbuminuria in children with sickle cell disease,” Pediatric Blood and Cancer, vol. 47, no. 1, pp. 71–76, 2006. View at Publisher · View at Google Scholar · View at Scopus
  570. A. Guasch, M. Cua, and W. E. Mitch, “Early detection and the course of glomerular injury in patients with sickle cell anemia,” Kidney International, vol. 49, no. 3, pp. 786–791, 1996. View at Google Scholar · View at Scopus
  571. L. Foucan, “A randomized trial of captopril for microalbuminuria in normotensive adults with sickle cell anemia,” American Journal of Medicine, vol. 104, no. 4, pp. 339–342, 1998. View at Publisher · View at Google Scholar · View at Scopus
  572. A. Guasch, J. Navarrete, K. Nass, and C. F. Zayas, “Glomerular involvement in adults with sickle cell hemoglobinopathies: prevalence and clinical correlates of progressive renal failure,” Journal of the American Society of Nephrology, vol. 17, no. 8, pp. 2228–2235, 2006. View at Publisher · View at Google Scholar · View at Scopus
  573. A. Guasch, C. F. Zayas, J. R. Eckman, K. Muralidharan, W. Zhang, and L. J. Elsas, “Evidence that microdeletions in the α globin gene protect against the development of sickle cell glomerulopathy in humans,” Journal of the American Society of Nephrology, vol. 10, no. 5, pp. 1014–1019, 1999. View at Google Scholar · View at Scopus
  574. A. Guasch, M. Cua, W. You, and W. E. Mitch, “Sickle cell anemia causes a distinct pattern of glomerular dysfunction,” Kidney International, vol. 51, no. 3, pp. 826–833, 1997. View at Google Scholar · View at Scopus
  575. N. Sundaram, M. Bennett, J. Wilhelm et al., “Biomarkers for early detection of sickle nephropathy,” American Journal of Hematology, vol. 86, no. 7, pp. 559–566, 2011. View at Publisher · View at Google Scholar · View at Scopus
  576. D. R. Wigfall, R. E. Ware, M. R. Burchinal, T. R. Kinney, and J. W. Foreman, “Prevalence and clinical correlates of glomerulopathy in children with sickle cell disease,” Journal of Pediatrics, vol. 136, no. 6, pp. 749–753, 2000. View at Google Scholar · View at Scopus
  577. V. R. Dharnidharka, S. Dabbagh, B. Atiyeh, P. Simpson, and S. Sarnaik, “Prevalence of microalbuminuria in children with sickle cell disease,” Pediatric Nephrology, vol. 12, no. 6, pp. 475–478, 1998. View at Publisher · View at Google Scholar · View at Scopus
  578. P. G. McBurney, C. D. Hanevold, C. M. Hernandez, J. L. Waller, and K. M. McKie, “Risk factors for microalbuminuria in children with sickle cell anemia,” Journal of Pediatric Hematology/Oncology, vol. 24, no. 6, pp. 473–477, 2002. View at Publisher · View at Google Scholar · View at Scopus
  579. B. A. Perkins, L. H. Ficociello, B. E. Ostrander et al., “Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes,” Journal of the American Society of Nephrology, vol. 18, no. 4, pp. 1353–1361, 2007. View at Publisher · View at Google Scholar · View at Scopus
  580. B. A. Perkins, L. H. Ficociello, K. H. Silva, D. M. Finkelstein, J. H. Warram, and A. S. Krolewski, “Regression of microalbuminuria in type 1 diabetes,” The New England Journal of Medicine, vol. 348, no. 23, pp. 2285–2293, 2003. View at Publisher · View at Google Scholar · View at Scopus
  581. K. I. Ataga, J. E. Brittain, D. Moore et al., “Urinary albumin excretion is associated with pulmonary hypertension in sickle cell disease: potential role of soluble fms-like tyrosine kinase-1,” European Journal of Haematology, vol. 85, no. 3, pp. 257–263, 2010. View at Publisher · View at Google Scholar · View at Scopus
  582. O. Alvarez, G. Zilleruelo, D. Wright, B. Montane, and G. Lopez-Mitnik, “Serum cystatin C levels in children with sickle cell disease,” Pediatric Nephrology, vol. 21, no. 4, pp. 533–537, 2006. View at Google Scholar
  583. W .Y. Wong et al., “Hematologic profile and lymphocyte subpopulations in hemoglobin SC disease: comparison with hemoglobin SS and black controls. The Transfusion Safety Study Group,” American Journal of Hematology, vol. 52, no. 3, pp. 150–154, 1996. View at Google Scholar
  584. D. R. Powars and C. S. Johnson, “Priapism,” Hematology/Oncology Clinics of North America, vol. 10, no. 6, pp. 1363–1372, 1996. View at Google Scholar · View at Scopus
  585. Z. R. Rogers, “Priapism in sickle cell disease,” Hematology/Oncology Clinics of North America, vol. 19, no. 5, pp. 917–928, 2005. View at Publisher · View at Google Scholar · View at Scopus
  586. A. M. Emond, R. J. Hayes, R. Holman, and G. R. Serjeant, “Priapism and impotence in homozygous sickle cell disease,” Archives of Internal Medicine, vol. 140, no. 11, pp. 1434–1437, 1980. View at Publisher · View at Google Scholar · View at Scopus
  587. R. E. Gradisek, “Priapism in sickle cell disease,” Annals of Emergency Medicine, vol. 12, no. 8, pp. 510–512, 1983. View at Google Scholar · View at Scopus
  588. A. B. Olujohungbe, A. Adeyoju, A. Yardumian et al., “A prospective diary study of stuttering priapism in adolescents and young men with sickle cell anemia: report of an international randomized control trial–the priapism in sickle cell study,” Journal of Andrology, vol. 32, no. 4, pp. 375–382, 2011. View at Google Scholar
  589. R. A. Seeler, “Intensive transfusion therapy for priapism in boys with sickle cell anemia,” Journal of Urology, vol. 110, no. 3, pp. 360–361, 1973. View at Google Scholar · View at Scopus
  590. M. Baron and E. Leiter, “The management of priapism in sickle cell anemia,” Journal of Urology, vol. 119, no. 5, pp. 610–611, 1978. View at Google Scholar · View at Scopus
  591. L. Krauss and T. Fitzpatrick, “The treatment of priapism by penile aspiration under controlled hypotension,” The Journal of Urology, vol. 85, pp. 595–598, 1961. View at Google Scholar · View at Scopus
  592. G. Karayalcin, M. Imran, and F. Rosner, “Priapism in sickle cell disease: report of five cases,” American Journal of the Medical Sciences, vol. 264, no. 4, pp. 289–293, 1972. View at Google Scholar · View at Scopus
  593. M. E. Conrad, G. M. Perrine, J. C. Barton, and J. R. Durant, “Provoked priapism in sicle cell anemia,” American Journal of Hematology, vol. 9, no. 1, pp. 121–122, 1980. View at Google Scholar · View at Scopus
  594. S. J. Galloway and A. L. Harwood-Nuss, “Sickle-cell anemia. A review,” Journal of Emergency Medicine, vol. 6, no. 3, pp. 213–226, 1988. View at Google Scholar · View at Scopus
  595. G. R. Serjeant, “The emerging understanding of sickle cell disease,” British Journal of Haematology, vol. 112, no. 1, pp. 3–18, 2001. View at Publisher · View at Google Scholar · View at Scopus
  596. G. R. Serjeant, K. De Ceulaer, and G. H. Maude, “Stilboestrol and stuttering priapism in homozygous sickle-cell disease,” The Lancet, vol. 2, no. 8467, pp. 1274–1276, 1985. View at Google Scholar · View at Scopus
  597. G. J. Kato, M. T. Gladwin, and M. H. Steinberg, “Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes,” Blood Reviews, vol. 21, no. 1, pp. 37–47, 2007. View at Publisher · View at Google Scholar · View at Scopus
  598. G. J. Kato, “Priapism in sickle-cell disease: a hematologist's perspective,” Journal of Sexual Medicine, vol. 9, no. 1, pp. 70–78, 2012. View at Publisher · View at Google Scholar · View at Scopus
  599. H. F. Bunn, D. G. Nathan, G. J. Dover et al., “Pulmonary hypertension and nitric oxide depletion in sickle cell disease,” Blood, vol. 116, no. 5, pp. 687–692, 2010. View at Publisher · View at Google Scholar · View at Scopus
  600. L. Hakim, A. Hashmat, R. Macchio, Priapism, S. H. Embury et al., Sickle Cell Disease Basic Principles and Clinical Practices, Raven Press, 1994.
  601. J. R. Sharpsteen Jr., D. Powars, C. Johnson, Z. R. Rogers, W. D. Williams, and R. J. Posch, “Multisystem damage associated with tricorporal priapism in sickle cell disease,” American Journal of Medicine, vol. 94, no. 3, pp. 289–295, 1993. View at Publisher · View at Google Scholar · View at Scopus
  602. E. Mantadakis, D. H. Ewalt, J. D. Cavender, Z. R. Rogers, and G. R. Buchanan, “Outpatient penile aspiration and epinephrine irrigation for young patients with sickle cell anemia and prolonged priapism,” Blood, vol. 95, no. 1, pp. 78–82, 2000. View at Google Scholar · View at Scopus
  603. C. A. Talacki and S. K. Ballas, “Modified method of exchange transfusion in sickle cell disease,” Journal of Clinical Apheresis, vol. 5, no. 4, pp. 183–187, 1990. View at Publisher · View at Google Scholar · View at Scopus
  604. J. F. Siegel, M. A. Rich, W. A. Brock, and H. N. Noe, “Association of sickle cell disease, priapism, exchange transfusion and neurological events: aspen syndrome,” Journal of Urology, vol. 150, no. 5, pp. 1480–1482, 1993. View at Google Scholar · View at Scopus
  605. C. A. Talacki and S. K. Ballas, “Modified method of exchange transfusion in sickle cell disease,” Journal of Clinical Apheresis, vol. 5, no. 4, pp. 183–187, 1990. View at Publisher · View at Google Scholar · View at Scopus
  606. C. Dawson and H. Whitfield, “ABC of Urology. Urological emergencies in general practice,” British Medical Journal, vol. 312, no. 7034, pp. 838–840, 1996. View at Google Scholar · View at Scopus
  607. W. W. Adamson and R. L. Ware, “Sickle dell anemia,” JAMA: The Journal of the American Medical Association, vol. 99, no. 11, pp. 902–905, 1932. View at Google Scholar
  608. J. A. Madel and A. P. Spivack, “Surgical management of sickle cell anemia: the use of packed red blood cell transfusions,” Annals of Internal Medicine, vol. 48, no. 2, pp. 399–406, 1958. View at Google Scholar · View at Scopus
  609. S. K. Ballas, “Sickle cell disease: clinical management,” Bailliere's Clinical Haematology, vol. 11, no. 1, pp. 185–214, 1998. View at Publisher · View at Google Scholar · View at Scopus
  610. G. R. Serjeant, Sickle Cell Disease, Oxford Medical, Oxford, UK, 2nd edition, 1992.
  611. E. S. Pearlman and S. K. Ballas, “When to transfuse blood in sickle cell disease? Lessons from Jehovah's Witnesses,” Annals of Clinical and Laboratory Science, vol. 24, no. 5, pp. 396–400, 1994. View at Google Scholar · View at Scopus
  612. K. F. Baum, D. T. Dunn, G. H. Maude, and G. R. Serjeant, “The painful crisis of homozygous sickle cell disease. A study of risk factors,” Archives of Internal Medicine, vol. 147, no. 7, pp. 1231–1234, 1987. View at Google Scholar · View at Scopus
  613. O. S. Platt, B. D. Thorington, D. J. Brambilla et al., “Pain in sickle cell disease—rates and risk factors,” The New England Journal of Medicine, vol. 325, no. 1, pp. 11–16, 1991. View at Google Scholar · View at Scopus
  614. S. K. Ballas, C. A. Talacki, V. M. Rao, and R. M. Steiner, “The prevalence of avascular necrosis in sickle cell anemia: correlation with α-thalassemia,” Hemoglobin, vol. 13, no. 7-8, pp. 649–655, 1989. View at Google Scholar · View at Scopus
  615. P. F. Milner, A. P. Kraus, J. I. Sebes et al., “Sickle cell disease as a cause of osteonecrosis of the femoral head,” The New England Journal of Medicine, vol. 325, no. 21, pp. 1476–1481, 1991. View at Google Scholar · View at Scopus
  616. C. S. Johnson, “Arterial blood pressure and hyperviscosity in sickle cell disease,” Hematology/Oncology Clinics of North America, vol. 19, no. 5, pp. 827–837, 2005. View at Publisher · View at Google Scholar · View at Scopus
  617. M. O. Russell, H. I. Goldberg, and L. Reis, “Transfusion therapy for cerebrovascular abnormalities in sickle cell disease,” Journal of Pediatrics, vol. 88, no. 3, pp. 382–387, 1976. View at Google Scholar · View at Scopus
  618. M. O. Russell, H. I. Goldberg, and A. Hodson, “Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell disease,” Blood, vol. 63, no. 1, pp. 162–169, 1984. View at Google Scholar · View at Scopus
  619. S. K. Ballas, “Iron overload is a determinant of morbidity and mortality in adult patients with sickle cell disease,” Seminars in Hematology, vol. 38, no. 1, supplement 1, pp. 30–36, 2001. View at Google Scholar · View at Scopus
  620. E. Drasar, N. Igbineweka, N. Vasavda et al., “Blood transfusion usage among adults with sickle cell disease—a single institution experience over ten years,” British Journal of Haematology, vol. 152, no. 6, pp. 766–770, 2011. View at Publisher · View at Google Scholar · View at Scopus
  621. E. P. Vichinsky, “Current issues with blood transfusions in sickle cell disease,” Seminars in Hematology, vol. 38, no. 1, supplement, pp. 14–22, 2001. View at Google Scholar · View at Scopus
  622. K. Ohene-Frempong, “Indications for red cell transfusion in sickle cell disease,” Seminars in Hematology, vol. 38, no. 1, supplement, pp. 5–13, 2001. View at Google Scholar · View at Scopus
  623. S. K. Ballas, “Sickle cell anaemia: progress in pathogenesis and treatment,” Drugs, vol. 62, no. 8, pp. 1143–1172, 2002. View at Google Scholar · View at Scopus
  624. K. R. DeVault, L. S. Friedman, S. Westerberg, P. Martin, B. Hosein, and S. K. Ballas, “Hepatitis C in sickle cell anemia,” Journal of Clinical Gastroenterology, vol. 18, no. 3, pp. 206–209, 1994. View at Google Scholar · View at Scopus
  625. T. G. St Pierre, P. R. Clark, and W. Chua-Anusorn, “Single spin-echo proton transverse relaxometry of iron-loaded liver,” NMR in Biomedicine, vol. 17, no. 7, pp. 446–458, 2004. View at Publisher · View at Google Scholar · View at Scopus
  626. N. F. Olivieri and G. M. Brittenham, “Iron-chelating therapy and the treatment of thalassemia,” Blood, vol. 89, no. 3, pp. 739–761, 1997. View at Google Scholar · View at Scopus
  627. J. J. Meerpohl, G. Antes, G. Rücker, N. Fleeman, C. Niemeyer, and D. Bassler, “Deferasirox for managing transfusional iron overload in people with sickle cell disease.,” Cochrane Database of Systematic Reviews (Online), vol. 8, article CD007477, 2010. View at Google Scholar · View at Scopus
  628. G. Lucania, A. Vitrano, A. Filosa, and A. Maggio, “Chelation treatment in sickle-cell-anaemia: much ado about nothing?” British Journal of Haematology, vol. 154, pp. 545–555, 2011. View at Publisher · View at Google Scholar · View at Scopus
  629. D. J. Pennell, V. Berdoukas, M. Karagiorga et al., “Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis,” Blood, vol. 107, no. 9, pp. 3738–3744, 2006. View at Publisher · View at Google Scholar · View at Scopus
  630. L. J. Anderson, B. Wonke, E. Prescott, S. Holden, J. M. Walker, and D. J. Pennell, “Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia,” The Lancet, vol. 360, no. 9332, pp. 516–520, 2002. View at Publisher · View at Google Scholar · View at Scopus
  631. C. Borgna-Pignatti, M. D. Cappellini, P. De Stefano et al., “Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major,” Blood, vol. 107, no. 9, pp. 3733–3737, 2006. View at Publisher · View at Google Scholar · View at Scopus
  632. A. Piga, C. Gaglioti, E. Fogliacco, and F. Tricta, “Comparative effects of deferiprone and deferoxamine on survival and cardiac disease in patients with thalassemia major: a retrospective analysis,” Haematologica, vol. 88, no. 5, pp. 489–496, 2003. View at Google Scholar · View at Scopus